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  ABSTRACT	  	  The	   field	   of	  Molecular	  Biology	   got	   started	   in	   earnest	  with	   the	   discovery	   of	   the	  molecular	  structure	  of	  DNA.	  This	  lead	  to	  a	  surge	  of	  interest	  into	  the	  relationships	  between	  DNA,	  RNA	  and	  proteins,	  and	   to	   the	  development	  of	   fundamental	   tools	  for	   manipulating	   those	   substances,	   such	   as	   cutting,	   ligating,	   amplifying,	  visualizing	   and	   size-­‐selecting	  DNA.	  With	   these	   tools	   at	   hand	   it	  was	   possible	   to	  begin	   sequencing	   DNA,	   a	   process	   that	   took	   a	   leap	   forward	   in	   2005	   with	   the	  advent	  of	  Next	  Generation	  Sequencing	  (NGS).	  An	   inherent	  problem	  with	  NGS	   is	  that	   both	   the	   sequencing	   process	   and	   the	   library	   preparation	   introduce	   errors	  and	  biases.	  The	  massive	  amount	  of	  data	  generated	  by	  NGS,	  and	  the	  use	  of	  NGS	  in	  clinical	  settings,	  has	  created	  a	  demand	  for	  methods	  that	  can	  account	  for	  this	  and	  thereby	  making	  the	  sequencing	  data	  correct	  and	  reproducible.	  	  	  Part	  1	  of	  this	  thesis	  briefly	  describes	  the	  development	  of	  Molecular	  Biology	  from	  the	  discovery	  of	  the	  molecular	  structure	  of	  DNA	  until	  today.	  Part	  2	  describes	  the	  development	   of	   error	   correcting	   and	   molecule	   counting	   methods,	   and	   part	   3	  describes	  the	  results	  of	  the	  papers	  of	  the	  thesis.	  	  Paper	   I	   introduces	   the	   concept	   of	   Unique	   Molecular	   Identifiers	   (UMI)	   for	  reducing	   noise	   in	   molecular	   karyotyping	   and	   RNA	   sequencing	   data.	   Paper	   II	  compares	   the	   use	   of	   UMIs,	   a	   novel	   amplification-­‐free	   method,	   and	   standard	  library	  preparation	   in	  Non-­‐Invasive	  Prenatal	  Testing	   (NIPT)	  of	   fetal	  karyotype.	  Paper	   III	   uses	   the	   UMI	   concept	   together	   with	   single-­‐cell	   tagged	   reverse	  transcription	   (STRT)	   to	   examine	   promoter	   preference	   in	   single	   cells.	   Finally	  paper	  IV	  use	  UMIs	  combined	  with	  PacBio	  sequencing	  to	  examine	  the	  full-­‐length	  transcriptome	  in	  single	  cells.	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   1	  
1	   MOLECULAR	  BIOLOGY	  	  
	  The	  blueprint	  of	  human	  life	  is	  found	  in	  the	  nucleus	  of	  each	  cell	  in	  our	  body	  and	  consists	   of	   23	   chromosome	   pairs	   containing	   two	   deoxyribonucleic	   acid	   (DNA)	  strands.	   The	   DNA	   molecule	   is	   built	   from	   sugar,	   phosphate	   and	   four	   variable	  bases:	  Adenine	   (A),	  Cytosine	   (C),	  Guanine	   (G)	   and	  Thymine	   (T).	  The	   sugar	  and	  phosphate	  make	  up	  the	  backbone	  of	  the	  DNA	  molecule,	  while	  the	  bases	  contain	  the	  genetic	  information.	  The	  combination	  of	  a	  sugar,	  phosphate	  and	  a	  base	  is	  the	  building	  block	  of	  DNA	  and	  is	  referred	  to	  as	  a	  nucleotide.	  The	  two	  strands	  of	  DNA	  are	  complementary,	  the	  base	  A	  pairs	  with	  T,	  and	  C	  pairs	  with	  G	  forming	  what	  is	  called	   a	   base	   pair	   (bp).	   The	   structure	   of	   DNA	  makes	   it	   suitable	   for	   copying	   as	  Watson	  and	  Crick	  stated	   in	   their	   seminal	  paper:	   “It	  has	  not	  escaped	  our	  notice	  that	   the	   specific	   pairing	   we	   have	   postulated	   immediately	   suggests	   a	   possible	  copying	  mechanism	  for	  the	  genetic	  material”	  (1).	  	  	  The	   DNA	   code	   is	  written	  with	   the	   four	   nucleotide	   letters	   A,	   C,	   G	   and	   T,	   and	   a	  typical	   gene	   is	   around	   10-­‐15	   kilobases	   (kb)	   long.	   While	   DNA	   contains	  information,	  it	  cannot	  perform	  any	  chemical	  work.	  	  The	  main	  functional	  units	  in	  cells	   are	   the	   proteins.	   To	   produce	   proteins,	   DNA	   is	   transcribed	   into	   a	   similar	  molecule,	   ribonucleic	   acid	   (RNA).	  The	  RNA	  molecule	   is	   then	   subjected	   to	  post-­‐transcriptional	  modifications	   that	   turns	   it	   into	   a	  mature	   RNA	  molecule,	   which	  can	  be	  substantially	  shorter	  than	  the	  pre-­‐mRNA.	  The	  RNAs	  that	  produce	  proteins	  are	  called	  messenger	  RNA	  (mRNA)	  and	  the	  average	  size	  of	  an	  mRNA	  molecule	  is	  around	   2	   kb.	   The	   transformation	   of	   mRNA	   to	   proteins	   is	   performed	   by	   the	  ribosome,	   and	   is	   referred	   to	   as	   translation.	   Proteins	   are	   translated	   by	   reading	  three	   consecutive	   RNA	   bases	   (codons)	   encoding	   one	   amino	   acid,	   and	   coupled	  serially	  to	  form	  a	  chain	  of	  amino	  acids.	  The	  amino	  acid	  chain	  folds	  into	  a	  three-­‐dimensional	   structure,	   and	   is	   subjected	   to	   post-­‐translational	   modifications,	  yielding	  a	  protein	  ready	  to	  perform	  its	  designated	  function.	  	  The	   central	   dogma	   of	   molecular	   biology,	   postulated	   by	   Francis	   Crick	   in	   1958,	  states	   that	   information	   flows	   in	   the	   direction	   from	  DNA	   to	  RNA	   to	   proteins.	   It	  also	  states	  that	  DNA	  can	  copy	  itself	  and	  that	  in	  special	  cases	  RNA	  can	  copy	  itself	  and	  make	   DNA,	   as	   has	   been	   seen	   in	   some	   viruses.	   However	   once	   a	   protein	   is	  formed	   it	   cannot	  be	   transformed	  back	   to	  RNA	  or	  DNA,	   and	  neither	   can	   it	   copy	  itself	  (2,	  3).	  The	  Central	  Dogma	  illustrates	  the	  key	  difference	  between	  molecular	  biology	  and	  the	  science	  from	  which	  it	  emerged,	  biochemistry.	  Whereas	  the	  latter	  is	  concerned	  with	  the	  flow	  of	  matter	  and	  energy,	  molecular	  biology	  is	  primarily	  concerned	  with	  the	  flow	  of	  information.	  	  	  
	  2	  
The	   DNA	   in	   all	   cells	   of	   an	   individual	   is	   identical	   with	   the	   exception	   of	   rare	  mutations	  that	  occur	  mainly	  during	  replication,	  so-­‐called	  somatic	  mutations.	  Still	  the	   phenotype	   of	   distinct	   cell	   types	   can	   be	   very	   different.	   This	   apparent	  contradiction	   is	   possible	   because	   specific	   regulatory	   programs	   are	   active	   in	  different	  cells	  and	  control	  what	  genes	  are	  expressed.	  No	  cell	  expresses	  all	  genes,	  and	   depending	   on	   which	   genes	   are	   expressed	   the	   cells	   will	   have	   different	  phenotypes	  and	  be	  able	  to	  perform	  different	  functions.	  	  After	  it	  was	  discovered	  that	  DNA	  was	  the	  substance	  that	  carried	  the	  heritability	  in	  cells,	  substantial	  effort	  was	  made	  to	  be	  able	  to	  read	  and	  manipulate	  the	  DNA	  code.	   Many	   new	   techniques	   were	   developed	   and	   some	   of	   them	   are	   still	   used	  today.	   This	   fascinating	  period	   and	   the	  discoveries	  made	  has	   been	  described	   in	  numerous	  books	  and	  nicely	  summarized	  in	  a	  review	  by	  Supratim	  Choudhuri	  (4).	  	  
1.1	   TOOLS	  USED	  IN	  MOLECULAR	  BIOLOGY	  	  To	   be	   able	   to	   separate	   and	   identify	   nucleic	   acids,	   gel	   electrophoresis	   was	  developed	  (5).	  It	  takes	  advantage	  of	  the	  negative	  charge	  of	  nucleic	  acids	  to	  drive	  them	   through	   a	   polyacrylamide	   or	   agarose	   gel	   by	   applying	   a	   current.	   Smaller	  molecules	  travel	  more	  quickly	  through	  the	  gel	  and	  can	  be	  separated	  from	  larger	  molecules.	  Molecules	  in	  the	  gel	  can	  also	  be	  visualized	  e.g.	  by	  dyes	  and	  ultraviolet	  light.	   	  Edwin	  Southern	  developed	  an	  application	  of	   this	  by	   transferring	   the	  gel-­‐separated	   DNA	   fragments	   to	   a	   paper	   and	   then	   hybridizing	   known	   radioactive	  RNA	  probes	  to	  the	  fragments	  allowing	  detection	  of	  specific	  DNA	  sequences.	  This	  became	  known	  as	  southern	  blotting	  (6).	  A	  similar	  technique	  was	  later	  developed	  for	   RNA	   and	   called	   Northern	   blotting	   (7).	   Southern	   blotting	   and	   many	   other	  methods	   depended	   on	   a	   technique	   that	   could	   cut	   DNA	   into	   smaller	   pieces.	   In	  1970	  Hamilton	  Smith	  and	  colleagues	  isolated	  a	  so	  called	  restriction	  enzyme	  from	  
Haemophilus	  influenza	  (8),	  and	  showed	  that	  it	  could	  cut	  DNA	  at	  specific	  positions	  in	   the	   genome	   that	   contained	   the	   base	   sequence	   AAGCTT.	   Soon,	   many	   more	  restriction	   enzymes	   were	   identified	   targeting	   different	   sequences.	   Around	   the	  same	  time	  enzymes	  performing	  the	  opposite	  reaction,	  that	  is	  the	  ligation	  of	  two	  DNA	  molecules,	  were	  discovered	   (9).	  During	   this	  productive	  period	   it	  was	  also	  discovered	   that	   DNA	   could	   be	   produced	   from	  RNA,	   a	   process	   that	  was	   named	  reverse	   transcription	   (10,	   11),	   which	   is	   a	   main	   tool	   in	   sequencing	   of	   RNA	  molecules	  today.	  	  By	  the	  mid	  1970s	  it	  was	  thus	  possible	  to	  cut	  and	  paste	  DNA,	  copy	  it	  to	  RNA	  and	  visualize	   it	   on	   a	   gel	   and	   identify	   specific	   DNA	   fragments.	   These	   methods	   to	  manipulate	  nucleic	  acids	  naturally	  led	  to	  experiments	  where	  scientists	  wanted	  to	  artificially	  change	  DNA	  in	  cells,	  and	  animals.	  The	  first	  recombinant	  DNA,	  that	   is	  DNA	  artificially	  formed	  by	  combining	  DNA	  from	  different	  species,	  was	  created	  in	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1972,	   by	   inserting	   the	   E.	   coli	   galactose	   operon	   into	   SV40	   viral	   DNA	   (12).	   This	  technique	  was	  soon	  applied	  to	  create	  recombinant	  plasmids	  that	  were	   inserted	  into	   bacteria,	   thereby	   forming	   the	   first	   recombinant	   organism	   (13).	   The	  following	  year,	  DNA	  was	  inserted	  into	  a	  murine	  blastocyst.	  The	  DNA	  integrated	  into	   the	   embryo	   genome,	   and	   after	   implantation	   into	   a	   pseudopregnant	  surrogate	  mother	  a	  healthy	  recombinant	  animal	  was	  born	  (14).	  	  Another	   breakthrough	   in	   the	   1970s	   was	   the	   first	   DNA	   sequencing	   methods,	  independently	  invented	  by	  Maxam	  and	  Gilbert	  (15)	  and	  Sanger	  (16,	  17).	  Sanger	  sequencing	   is	   still	   the	   golden	   standard	   to	   verify	   discoveries	   made	   by	   other	  methods.	   The	   method	   is	   based	   on	   chain-­‐terminating	   inhibitors.	   DNA	   is	  sequenced	   by	   adding	   an	   oligonucleotide	   primer	   to	   the	   template	   and	   then	  allowing	   the	   primer	   to	   extend	   in	   a	  mixture	   of	   normal	   deoxynucleotides	   and	   a	  much	  smaller	  amount	  of	  a	  specific	  dideoxynucleotide	  (ddN,	  N	  symbolizes	  any	  of	  the	  bases	  A,	  C,	  G	  or	  T)	   that	   terminate	   the	  elongation	  when	   incorporated.	   If	   the	  dideoxynucleotide	   is	   ddA,	   then	   for	   each	   A	   position	   in	   the	   template	   some	  extending	   strands	   will	   terminate	   their	   reactions,	   creating	   oligonucleotides	   of	  different	   length.	  The	  difference	   in	  extension	   length	  can	   then	  be	  visualized	  on	  a	  polyacrylamide	   gel.	   When	   repeated	   for	   all	   four	   bases	   the	   sequence	   of	   the	  template	  molecule	  can	  be	  read	  just	  by	  examining	  the	  gel.	  	  A	   great	   improvement	   to	   the	   molecular	   toolbox	   came	   in	   1985	   with	   the	  development	   of	   polymerase	   chain	   reaction	   (PCR)	   amplification	   (18).	   This	  allowed	   the	   amplification	   of	   a	   single	   DNA	   molecule	   to	   in	   theory	   unlimited	  amounts	  of	  copies	  of	  the	  molecule	  with	  the	  help	  of	  two	  oligonucleotide	  primers	  and	   a	  DNA	  polymerase.	   In	   PCR	   a	   double-­‐stranded	  DNA	  molecule	   is	   denatured,	  then	  one	  primer	  hybridizes	  to	  the	  (+)	  strand	  and	  the	  other	  primer	  hybridizes	  to	  the	   (-­‐)	   strand.	  Both	  primers	   are	   extended	   leading	   to	   two	   copies	  of	   the	  original	  double-­‐stranded	   DNA	   molecule.	   This	   process	   is	   repeated	   until	   enough	   copies	  have	  been	  generated	  for	  the	  application	  of	  interest.	  	  With	  Sanger	  sequencing	  and	  PCR	  amplification	  at	  hand	  leading	  scientists	  started	  to	   advocate	   the	   sequencing	   of	   the	   human	   genome,	   a	   milestone	   that	   was	  completed	  in	  2001	  (19,	  20).	  The	  Human	  Genome	  Project	  (HGP)	  took	  11	  years	  to	  complete	   and	   was	   achieved	   with	   Sanger	   sequencing.	   This	   was	   the	   first	   “Big	  Science”	  project	  in	  the	  history	  of	  molecular	  biology	  and	  a	  number	  of	  large-­‐scale	  projects	  have	  followed	  since	  then.	  	  	  New	   exciting	   tools	   in	  molecular	   biology	   keep	   emerging.	   For	   example	   it	   is	   now	  possible	   to	  control	  neuronal	  activation	  by	   light.	  When	  deciphering	  the	   intricate	  networks	  of	  the	  brain	  it	  is	  important	  to	  be	  able	  to	  turn	  on	  or	  off	  specific	  neurons,	  or	  types	  of	  neurons,	  with	  temporal	  precision	  (21).	  This	  was	  first	  tested	  in	  2005	  (22)	   and	   later	   termed	   optogenetics.	   Boyden	   et	   al	   inserted	   a	   protein	   called	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Channelrhodopsin	  2	  (ChR2)	  into	  cultured	  rat	  neurons.	  ChR2	  is	  a	  transmembrane	  protein	  that	  responds	  to	  blue	   light	  by	  a	  conformational	  change	  that	  opens	  up	  a	  pore	  in	  the	  membrane	  and	  lets	  cations	  enter	  the	  cell.	  It	  was	  shown	  that	  pulses	  of	  blue	  light	  indeed	  could	  induce	  depolarization	  (neuronal	  activation).	  Optogenetics	  is	  now	  a	  commonly	  used	  tool	  in	  neurobiology.	  	  	  One	  tool	  that	  has	  captured	  the	  imagination	  of	  scientists,	  media	  and	  laymen	  alike,	  is	   the	   Clustered	   Regularly	   Interspaced	   Short	   Palindromic	   Repeats	   –	   CRISPR-­‐associated	   protein-­‐9	   nuclease	   (CRISPR-­‐CAS9)	   system	   for	   genome	   engineering.	  Originally	   used	   as	   a	   defence	   system	   against	   foreign	   pathogens	   in	   bacteria,	   the	  same	  mechanism	  is	  now	  be	  used	  to	  disrupt	  or	  insert	  genomic	  content	  at	  specific	  locations	   in	   a	   genome	   (23).	   The	   power	   of	   CRISPR-­‐CAS9	   stems	   from	   its	  programmability,	  making	  it	  possible	  to	  target	  specific	  chromosomal	  locations	  at	  will,	  with	  nearly	  single-­‐nucleotide	  precision.	  	  
1.2	   NEXT	  GENERATION	  SEQUENCING	  	  Upon	  completion	  of	   the	  HGP	   the	  stage	  was	  set	   for	  Next	  Generation	  Sequencing	  (NGS).	   Five	   reasons	   for	   the	   development	   have	   been	   identified.	   First,	   Sanger	  sequencing	   had	   been	   optimized	   to	   the	   point	   that	   further	   optimizations	   were	  unlikely	   to	   significantly	   improve	   cost	   or	   throughput.	   Second,	   the	   availability	   of	  the	   human	   genome	  made	   short-­‐read	   sequencing	   much	   more	   powerful.	   It	   was	  now	  possible	  to	  use	  the	  known	  human	  genome	  to	  map	  short	  sequences	  to	  their	  correct	   places	   in	   the	   genome.	   Third,	   many	   molecular	   methods	   had	   been	  developed	   that	   could	   benefit	   from	   high-­‐throughput	   sequencing,	   like	   RNA-­‐expression	   and	   protein-­‐DNA	   interactions.	   Fourth,	   technological	   development	  across	   a	   number	   of	   fields	   (e.g.	   microscopy,	   surface	   chemistry	   and	   polymerase	  engineering)	  made	  alternative	  strategies	  for	  DNA	  sequencing	  more	  feasible	  (24).	  Added	   to	   this	   list	   should	   be	   the	   increase	   of	   computing	   power	   to	   handle	   the	  massive	  amount	  of	  data	  generated.	  	  A	   number	   of	   new	   sequencing	   methods	   were	   developed	   at	   this	   time	   and	   have	  been	   excellently	   reviewed	   elsewhere	   (24).	   Here	   I	   would	   like	   to	   focus	   on	   the	  methods	  used	  in	  my	  work:	  Sequencing	  By	  Synthesis	  (SBS)	  here	  demonstrated	  by	  the	   Illumina	   approach	   and	   Single	   Molecule	   Real	   Time	   (SMRT)	   sequencing	   as	  demonstrated	  by	  Pacific	  Biosciences	  (PacBio).	  	  In	  Illumina	  DNA	  sequencing,	  a	  genome	  is	  first	  fragmented	  into	  smaller	  molecules	  either	  by	  physical	  shearing	  or	  enzymatic	  cleavage.	  The	  ends	  of	  the	  molecules	  are	  then	   repaired	   enzymatically	   to	   form	   complete	   double-­‐stranded	   templates.	  Adapters	  are	  ligated	  to	  the	  templates,	  and	  template	  molecules	  are	  subsequently	  denatured.	   The	   single-­‐stranded	   templates	   are	   then	   hybridized	   to	   an	   array	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consisting	   of	   short	   molecules	   complementary	   to	   parts	   of	   the	   adapters.	   These	  short	  molecules	   function	   as	  primers	   in	   a	  PCR	   reaction	   and	   template	  molecules	  amplify	   in	   a	   reaction	   called	   bridge	   amplification,	   forming	   dense	   clusters	   of	  amplified	   copies	   of	   the	   template.	   The	   generation	   of	   clusters	   is	   necessary	   to	  increase	  signal	  to	  noise	  ratio	  when	  sequencing.	  Molecules	  are	  then	  made	  single-­‐stranded	  again	  and	  a	  sequencing	  primer	  is	  hybridized	  to	  the	  template	  clusters	  to	  a	   universal	   region	   on	   the	   adapter	   flanking	   the	   region	   of	   interest.	   Primers	   are	  extended	  one	  base	  at	  a	  time	  by	  nucleotides	  modified	  to	  function	  as	  a	  reversible	  terminator,	   i.e.	   the	   3’	   end	   is	  modified	   not	   to	   allow	   incorporation	   of	   additional	  nucleotides.	   The	   modification	   is	   reversible	   and	   can	   be	   removed	   in	   a	   cleavage	  reaction.	   Each	   different	   type	   of	   nucleotide	   also	   has	   a	   removable	   fluorophore	  attached	   with	   a	   specific	   colour.	   A	   sequencing	   cycle	   consists	   of	   adding	   all	   four	  modified	   nucleotides,	   allow	   base	   extension	   by	   a	   polymerase,	   image	   to	   capture	  the	  fluorescence	  of	   the	  added	  nucleotide	  and	  finally	  removal	  of	   fluorescent	  dye	  and	   the	   terminator	   to	   allow	   the	  next	   cycle	  of	  base	  extension	   (24,	  25).	   Illumina	  sequencing	  is	  the	  most	  successful	  NGS	  method	  so	  far	  and	  has	  a	  large	  part	  of	  the	  sequencing	  market.	  However	  it	  has	  limitations	  in	  terms	  of	  read	  length	  where	  the	  maximum	  to	  date	  is	  700	  bp.	  	  The	  SMRT	  sequencing	  method	  is	  very	  different	  from	  Illumina	  sequencing.	  It	  uses	  an	  aluminium	  block	  consisting	  of	  many	  small	  wells	  attached	   to	  a	  glass	   surface.	  Each	   well	   has	   a	   polymerase	   enzyme	   attached,	   and	   single	   circularized	   DNA	  molecules	  are	  stochastically	  added	  so	  that	  each	  well	  gets	  a	  single	  molecule	  based	  on	  Poisson	  statistics.	  Similar	  to	  Illumina	  sequencing	  a	  primer	  is	  used	  to	  start	  the	  sequencing	  reaction.	  Nucleotides	  with	  a	  fluorescent	  molecule	  attached	  are	  added	  to	   the	   wells,	   and	   the	   incorporation	   of	   a	   nucleotide	   to	   the	   extending	   primer	  results	  in	  cleavage	  of	  the	  fluorophore.	  Because	  nucleotide	  incorporation	  is	  slow	  relative	  to	  the	  diffusion	  rate,	  this	  event	  can	  be	  detected	  and	  used	  for	  base	  calling.	  Thus,	   the	   fluorophore	   from	  a	   single	   incorporated	  nucleotide,	  which	   remains	   in	  the	  well	  for	  hundreds	  of	  milliseconds,	  can	  be	  distinguished	  from	  fluorophore	  of	  freely	   diffusing	   nucleotides,	   which	   shuttle	   in	   and	   out	   at	   sub-­‐millisecond	  timescales.	  To	  successfully	  image	  a	  single	  nucleotide	  incorporation	  event	  from	  a	  single	  polymerase	  and	  identify	  the	  increase	  in	  fluorescence,	  the	  reaction	  volume	  must	  be	  very	  small.	  This	  is	  achieved	  by	  making	  the	  wells	  in	  the	  aluminium	  plate	  so	   small	   that	   the	   reaction	   volume	   is	  measured	   in	   zeptoliters	   (10-­‐21	   liter)	   (26).	  The	  main	  benefit	  of	  PacBio	  sequencing	  is	  the	  read	  length	  that	  can	  cover	  several	  kb,	  however	  the	  throughput	  is	  limited	  compared	  to	  Illumina	  sequencing.	  	  Next	  generation	  sequencing	  has	  made	  possible	  a	  number	  of	  large-­‐scale	  projects.	  A	   common	   aim	   of	   these	   projects	   is	   to	   systematically	   and	   in	   depth	   examine	  questions	   of	   particular	   importance	   in	  molecular	   biology,	   typically	   generating	   a	  massive	  amount	  of	  data	  to	  allow	  computational	  and	  mathematical	  modelling	  to	  provide	   answers	   to	   the	   question.	   This	   is	   sometimes	   referred	   to	   as	   systems	  
	  6	  
biology.	  A	   typical	   example	   is	  The	  Cancer	  Genome	  Atlas	   that	   catalogues	   genetic	  mutations	   responsible	   for	   cancer.	   Other	   examples	   include	   the	   Encyclopedia	   of	  DNA	  Elements	  (ENCODE),	  which	  aims	  to	  build	  a	  list	  of	  functional	  elements	  in	  the	  human	  genome.	  One	  controversial	  finding	  of	  ENCODE	  is	  that	  most	  of	  the	  human	  genome,	  around	  80%,	  are	  in	  some	  way	  active	  in	  at	   least	  one	  cell	  type	  (27),	  and	  it’s	  implicated	  that	  a	  large	  part	  of	  that	  is	  also	  functional.	  A	  serious	  critique	  of	  this	  finding	  is	  that	  only	  around	  10%	  of	  the	  genome	  is	  evolutionarily	  conserved	  (28),	  implying	   that	   the	   majority	   of	   the	   genome	   is	   expendable	   and	   probably	   not	  functional.	   Another	   large-­‐scale	   project	   is	   the	   Functional	   annotation	   of	   the	  mammalian	   genome	   (FANTOM)	   project,	   which	   aims	   to	   assign	   functional	  annotation	   to	   full-­‐length	   cDNA.	   Recently	   the	   FANTOM	   project	   mapped	  transcription	  start	  sites	  (TSS)	  by	  their	  Cap	  Analysis	  of	  Gene	  Expression	  (CAGE)	  method,	  and	  data	  from	  this	  effort	  has	  been	  used	  in	  paper	  III.	  	  
	  
1.3	   THE	  NEED	  FOR	  ENHANCED	  PRECISION	  IN	  SEQUENCING	  	  The	   ideal	   sequencing	  method	   should	   be	   able	   to	   take	   a	   tube	   filled	  with	   nucleic	  acids	   and	   translate	   all	   molecules	   in	   the	   tube	   into	   correct	   sequences	   in	   the	  computer.	  This	   is	  not	  possible	  today	  because	  all	  sequencing	  methods	  introduce	  bias	  and	  errors	  when	  converting	  the	  chemical	  molecules	  into	  digital	  information.	  Also	   sequencing	   instruments	   require	   that	   input	   molecules	   comes	   in	   a	   certain	  form	  and	  quantity.	  This	  transformation	  of	  genomic	  DNA	  or	  RNA	  into	  molecules	  suitable	   for	   a	   certain	   instrument	   is	   called	   library	   preparation,	   and	   this	  processing	  also	  introduces	  bias	  and	  errors.	  An	  especially	  biased	  and	  error	  prone	  step	  during	   library	  preparation	   is	   the	   amplification	   step,	  which	   is	  necessary	   in	  many	  protocols.	  	  For	  many	  applications	   it	   is	   important	   to	  distinguish	  artefactual	  mutations	   from	  the	   library	   preparation	   and	   sequencing	   processes,	   from	   real	   mutations	   in	   the	  genome.	   Consider	   the	   case	   of	   monitoring	   residual	   disease	   in	   leukaemia.	   The	  ability	   to	   identify	   early	   on	   the	   type	   of	   mutation	   that	   renders	   a	   cancer	   clone	  resistant	   to	   therapy	   can	   be	   the	   difference	   between	   life	   and	   death.	   However	   if	  library	  preparation	  and	   sequencing	   introduce	  errors	  of	   a	  magnitude	  of	  1	  error	  per	  100	  bases	  sequenced,	  mutations	  with	  a	  frequency	  of	  less	  than	  1%	  will	  not	  be	  accurately	   called.	   This	   means	   that	   a	   relapsing	   clone	   already	   has	   a	   substantial	  amount	  of	  copies	  before	  it	  can	  be	  identified	  and	  addressed.	  	  	  Tools	   have	   been	   developed	   to	   greatly	   improve	   quantification	   and	   decrease	  errors	  in	  sequencing	  data.	  Part	  2	  of	  this	  thesis	  discuss	  why	  these	  tools	  have	  been	  developed,	   how	   they	   work	   and	   in	   what	   areas	   of	   molecular	   biology	   they	   have	  been	  applied.	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2	   COUNTING	  AND	  ACCURATELY	  SEQUENCING	  NUCLEIC	  
ACIDS	  	  
2.1	   INTRODUCTION	  	  There	   is	   a	   need	   for	   more	   accurate	   and	   quantitative	   measurements	   of	   nucleic	  acids	   than	   what	   is	   possible	   with	   the	   sequencing	   technologies	   available	   today,	  especially	   in	   the	   biomedical	   areas.	   This	   need	   is	   accentuated	   in	   cases	   where	  extensive	   amplification	   is	   needed,	   such	   as	   single	   cell	   sequencing,	   targeted	  sequencing	  of	  rare	  mutations	  or	  sequencing	  of	  clinical	  material	  where	  only	  very	  small	  amounts	  are	  available.	  	  The	  methods	  developed	  to	  increase	  accuracy	  of	  sequencing	  data	  involve	  marking	  individual	  molecules	  with	  a	  molecular	  barcode	  and	  thereby	  making	  them	  unique.	  This	   allows	   both	   for	   accurate	   quantification	   and	   error	   correction.	   Since	  previously	   identical	   molecules	   are	   now	   unique,	   it	   is	   possible	   to	   count	   the	  molecules	  even	  after	  amplification,	  and	  by	  comparing	  multiple	  copies	  belonging	  to	  a	  single	  molecule	   it	   is	  possible	  to	   identify	  artefactual	  mutations	  coming	  both	  from	  clonal	  amplification	  errors	  and	  random	  errors	  produced	  by	  sequencing.	  	  	  Part	   2	   of	   this	   thesis	   describes	  why	   it	   is	   important	   use	  molecular	   barcoding	   of	  individual	   molecules,	   how	   the	   method	   was	   developed,	   and	   the	   different	  strategies	  used	  to	  improve	  quantification	  and	  error	  correction	  of	  NGS	  data.	  It	  will	  also	   show	   a	   number	   of	   examples	  where	   the	   barcoding	   strategy	   has	   been	   used	  and	   compare	   the	   different	   barcoding	   strategies.	   Finally	   it	   summarizes	   the	  developments	  made	  to	  the	  barcoding	  strategy	  and	  discusses	  pitfalls	  that	  should	  be	  avoided.	  	  
2.1.1	   Amplification-­‐induced	  bias	  	  Illumina	   sequencing	   is	   the	   most	   widely	   used	   sequencing	   technology	   today,	  mainly	   due	   to	   its	   high	   throughput	   and	   accuracy.	   Illumina	   sequencing	   usually	  requires	   amplification	   during	   library	   preparation	   and	   then	   another	   round	   of	  solid-­‐phase	   amplification	   during	   the	   sequencing	   reactions.	   Amplification	   is	  always	  uneven	  and	   introduces	  errors,	  although	  substantial	   improvements	  have	  been	  achieved	  in	  polymerase	  efficiency	  and	  fidelity.	  For	  example	  AccuPrime	  Pfx	  has	  been	  shown	  to	  have	  an	  error	  rate	  of	  2.9	  x	  10-­‐6	  (29)	  and	  KAPA	  HiFi	  claims	  an	  error	   rate	   of	   2.8	   x	   10-­‐7	   (30).	   Some	   molecules,	   usually	   short	   molecules	   with	   a	  normal	   GC	   (Guanine	   -­‐	   Cytosine)	   content	   and	   no	   secondary	   structures,	   amplify	  more	  efficiently	  than	  others.	  The	  extent	  of	  this	  bias	  varies	  substantially	  with	  the	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polymerase	  used	  (31).	  Interestingly	  a	  recent	  study	  using	  AccuPrime	  Pfx	  showed	  with	  both	  theoretical	  modeling	  and	  experimental	  evidence	  that	  the	  main	  source	  of	   PCR	   error	   is	   stochasticity	   of	   amplification	   in	   the	   first	   rounds	   of	   PCR	  amplification,	  followed	  by	  polymerase	  errors.	  GC	  content	  and	  template	  switching	  had	  only	  minor	  influence	  (32).	  	  	  Amplification	  creates	  four	  problems	  as	  illustrated	  in	  figure	  1.	  The	  first	  problem	  regards	   quantification.	   If	   X	   DNA	   molecules	   with	   the	   exact	   same	   base	   pair	  sequence	   are	   amplified,	   and	   the	   amplification	   efficiency	   is	   unknown,	   then	  information	  about	  X	   is	   lost.	  The	  second	  problem	  has	  to	  do	  with	   introduction	  of	  errors.	  Amplification	  introduces	  errors	  depending	  on	  factors	  such	  as	  the	  number	  of	  cycles	  of	  amplification,	  polymerase	  fidelity	  and	  read	  length.	  Errors	  consist	  of	  base	   pair	   substitutions,	   deletions	   or	   insertions,	   or	   in	   the	   form	   of	   template	  switching	  where	  the	  final	  PCR	  product	  consists	  of	  a	  combination	  of	  two	  or	  more	  molecules.	  The	  third	  problem	  has	  to	  do	  with	  redundant	  information.	  Sequencing	  data	  from	  a	  highly	  amplified	  library	  will	  contain	  many	  copies	  of	  transcripts	  that	  don’t	   provide	   additional	   information.	   In	   other	   words	   the	   yield,	   defined	   as	   the	  number	  of	   informative	  bases	  divided	  by	   the	   total	  number	  of	  bases,	   is	   low.	  The	  fourth	   problem	  has	   to	   do	  with	   loss	   of	   information.	   Poorly	   amplified	  molecules	  will	  be	  sequenced	  to	  a	  much	  lesser	  extent,	  e.g.	  leaving	  large	  areas	  with	  aberrant	  GC	   content	   unsequenced	   in	   genomic	   sequencing.	   In	   conclusion,	   amplification	  doesn’t	   only	   confuse	   the	   analysis	   by	   introducing	   errors	   and	   bias;	   it	   also	   limits	  sequencing	   capabilities	   by	   repeatedly	   sequencing	   the	   same	   molecules	   while	  leaving	  out	  regions	  from	  being	  analysed.	  	  A	   couple	   of	   methods	   have	   been	   developed	   to	   deal	   with	   the	   quantification	  problem.	   For	   example,	   a	   patient	   sample	   and	   a	  healthy	   control	   can	  be	   analysed	  simultaneously	   and	   since	   the	   amplification	   efficiency,	   which	   depends	   on	   GC	  content,	   length	   and	   secondary	   structures	   of	   the	   DNA,	   should	   be	   similar	   in	   the	  sample	  and	  control,	  it	  is	  possible	  to	  get	  an	  estimation	  of	  the	  relative	  abundance	  of	  gene	  transcripts	   in	  the	  sample.	  It	   is	  not	  possible	  to	  determine	  the	  number	  of	  unique	  molecules,	  but	  it	  is	  possible	  to	  determine	  if	  there	  is	  an	  overall	  increase	  or	  decrease	  in	  gene	  expression	  in	  the	  sample	  compared	  to	  the	  control.	  	  	  It	  can	  be	  very	  important	  to	  get	  an	  exact	  quantification	  of	  the	  number	  of	  identical	  molecules	  in	  a	  sample,	  e.g.	  to	  determine	  the	  number	  of	  cells	  with	  a	  mutant	  allele	  in	   cancer	   diagnostics	   or	   in	   monitoring	   of	   residual	   disease.	   Digital	   PCR	   was	  developed	  to	  this	  end	  (33).	  In	  digital	  PCR	  DNA	  is	  diluted	  to	  a	  low	  concentration	  and	  divided	  into	  wells	  in	  a	  plate	  so	  that	  each	  well	  contains	  only	  one	  copy	  of	  the	  template	  molecule.	  Each	  molecule	  is	  then	  amplified	  and	  detected.	  This	  allows	  an	  exact	   quantification	   of	   the	   number	   of	   participating	   molecules,	   however	   the	  throughput	   is	   low,	   allowing	  only	   for	   querying	   a	   limited	  number	  of	   targets	   at	   a	  time	  (34).	  	  




Figure	  1:	  Problems	  related	  to	  amplification	  of	  molecules	  before	  sequencing.	  Four	   problems	   are	   created	   by	   the	   amplification	   process:	   loss	   of	   quantification,	   introduction	   of	  errors,	  uneven	  representation	  of	  genomic	  regions	  and	  introduction	  of	  uninformative	  molecules.	  
	  
2.1.2	   Unique	  Molecular	  Identifiers	  	  Unique	  Molecular	   Identifiers	   (UMI)	   was	   introduced	   as	   a	  measure	   to	   solve	   the	  quantification	   and	   error-­‐introduction	   problems	   of	   amplification.	   A	   UMI	   is	   a	  barcode	  that	  is	  attached	  to	  the	  template	  molecule	  in	  an	  early	  step	  of	  the	  library	  preparation.	   The	   barcodes	   make	   each	   molecule	   unique	   before	   amplification.	  What	  does	  this	  mean?	  A	  simple	  analogy	  would	  be	  the	  problem	  of	  retrieving	  your	  traveling	  bag	  after	  a	  flight.	  Often	  people	  waiting	  at	  the	  baggage	  carousel	  have	  the	  exact	   same	  brand	  of	   traveling	  bag	  and	   it	   is	   impossible	   to	   tell	   them	  apart.	  Your	  simple	   black	   bag	   is	   not	   possible	   to	   tell	   apart	   from	   the	   other	   black	   bags	   going	  around	   on	   the	   carousel.	   To	   solve	   this	   problem	   savvy	   travellers	   have	   begun	   to	  














mark	  their	  bags	  with	  colourful	  belts	  or	  silly	  stickers,	  and	  that	  is	  exactly	  what	  the	  UMI	  does.	  The	  classical	  approach	  is	  to	  ligate	  a	  barcode	  consisting	  of	  a	  number	  of	  random	  nucleotides.	   If	   the	   length	   of	   the	  barcode	   is	   sufficient	   in	   relation	   to	   the	  number	   of	   identical	   molecules	   in	   the	   sample	   then	   the	   chance	   is	   low	   that	   two	  identical	  barcodes	  ligate	  to	  two	  identical	  molecules	  and	  each	  molecule	  therefore	  becomes	   unique.	  When	   each	  molecule	   is	   unique,	   quantitative	   information	   will	  not	  be	  lost	  by	  amplification.	  	  Molecular	  barcodes	  can	  solve	  the	  quantification	  problem	  and	  correct	   for	  errors	  created	  by	  amplification,	  however	   they	  cannot	   identify	   transcripts	   that	  amplify	  poorly	   and	   each	   barcode	   is	   often	   sequenced	  multiple	   times	   resulting	   in	  many	  non-­‐informative	   sequence	   reads.	   To	   sequence	   genomic	   regions	   that	   amplify	  poorly	  or	  to	  sequence	  only	  new	  molecules	  an	  amplification-­‐free	  method	  should	  be	  used	  (35).	  	  Molecular	  barcoding	  of	  individual	  DNA	  molecules	  to	  improve	  quantification	  was	  first	  proposed	  in	  2003	  (36).	  Already	  in	  2004	  the	  theory	  was	  put	  into	  practice	  for	  the	  first	  time	  (37),	  and	  this	  was	  followed	  up	  and	  improved	  by	  the	  same	  group	  in	  2007	   (38).	   In	   2010	   Konig	   et	   al	   also	   used	   the	  molecular	   barcoding	   strategy	   to	  discriminate	   between	   unique	   DNA	   sequences	   and	   PCR	   duplicates	   (39).	   Using	  molecular	   barcodes	   to	   create	   a	   consensus	   sequence	   for	   error	   correction	   was	  introduced	   soon	   thereafter	   (34,	   40-­‐43).	   By	   2012	   the	   concept	   was	   well	  established	   and	   had	   been	   used	   in	   a	   number	   of	   different	   settings,	   among	   these	  amplicon	  sequencing	  of	  a	  viral	  RNA,	   identification	  of	  mutation	   frequencies	   in	  a	  small	  genomic	  region	  and	  karyotyping	  of	  cell-­‐free	  DNA.	  The	  coming	  years	  saw	  a	  number	   of	   tweaks	   and	   improvements	   to	   the	   method	   and	   by	   now	   it	   has	   been	  referred	  to	  in	  more	  than	  100	  scientific	  papers.	  	  
2.1.3	   Turning	  a	  quantitative	  problem	  into	  a	  qualitative	  problem	  
	  One	   of	   the	   first	   uses	   of	   the	   concept	   of	  molecular	   barcoding	  were	   in	   signature-­‐tagged	   mutagenesis	   (44,	   45),	   to	   track	   the	   origins	   of	   expressed	   sequence	   tags	  (what	  is	  now	  be	  called	  multiplexing)	  (46)	  and	  in	  labelling	  objects	  with	  DNA	  for	  identification	  (47,	  48).	  	  
	  The	   first	   paper	   to	   mention	   molecular	   barcoding	   of	   individual	   molecules	   to	  reduce	  amplification-­‐induced	  bias	  was	  a	  theoretical	  paper	  by	  Hug	  and	  Schuler	  in	  2003	   (36).	   They	   proposed	   turning	   the	   quantitative	   problem	   of	   counting	   exact	  number	   of	   molecules	   of	   a	   single	   mRNA	   species	   in	   complex	   soup	   of	   mRNA	  molecules,	   into	   a	   qualitative	   problem	   by	   making	   each	   individual	   molecule	  unique.	  Another	  way	   to	  describe	   the	  solution	   is	   to	  contrast	   it	   to	  digital	  PCR:	   In	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digital	  PCR	  molecules	  are	  separated	  in	  the	  physical	  space,	  in	  molecular	  barcoding	  molecules	  are	  separated	  in	  the	  chemical	  space	  (49).	  	  	  
	  	  
Figure	   2:	   Molecular	   barcoding	   of	   individual	   molecules	   to	   correct	   for	   quantification	   bias.	  Comparison	  between	  amplification	  of	  molecules	  with	  and	  without	  a	  molecular	  barcode.	  Here	  five	  identical	   molecules	   are	   amplified.	   To	   the	   left,	   amplification	   with	   a	   barcode.	   To	   the	   right,	  amplification	  without	   a	   barcode.	  When	   a	   library	  with	   barcodes	   is	   amplified	   it	   is	   easy	   to	   keep	  track	  of	  the	  number	  of	  original	  molecules,	  provided	  that	  each	  molecule	  is	  sequenced	  at	  least	  once.	  When	   amplification	   is	   done	   without	   barcodes	   information	   about	   the	   number	   of	   original	   pre-­‐amplified	  molecules	  is	  lost.	  	  The	  method	  was	  suggested	  to	  comprise	  of	  four	  steps:	  First	  to	  isolate	  the	  mRNA	  species	  of	  interest,	  second	  to	  make	  each	  mRNA	  molecule	  unique,	  into	  something	  they	   called	   Different	   Molecular	   Species	   (DMS),	   third	   to	   amplify	   the	   DMS	   and	  fourth	   to	   detect	   and	   count	   the	   DMS	   (outlined	   in	   figure	   2).	   Thereby	   the	  quantitative	   problem	   of	   counting	   mRNA	   molecules	   of	   a	   certain	   species	   was	  transformed	   into	   the	   qualitative	   problem	   of	   detecting	   DMS.	   The	   qualitative	  
Set of identical molecules pre PCR
Introduce a molecular barcode 
to make each molecule unique
Amplify and sequence
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problem	  is	  solvable	  just	  by	  sequencing	  deeper,	  that	  is	  the	  sensitivity	  for	  picking	  up	   new	   DMS	   increases	   with	   sequencing	   depth,	   and	   thereby	   the	   resolution	   in	  counting	   molecules	   improves.	   This	   is	   in	   contrast	   to	   the	   quantitative	   problem	  where	   increased	   sequencing	   depth	   doesn’t	   improve	   counting	   resolution,	   since	  additional	  copies	  of	  the	  same	  molecule	  don’t	  add	  more	  information.	  	  
2.1.4	   Putting	  theory	  into	  practice	  
	  In	  2004	  the	  method	  was	  invented	  again	  and	  this	  time	  it	  was	  applied	  to	  bisulphite	  sequencing	   of	   the	   FMR1	   promoter	   region	   in	   the	   DNA	   of	   males	   with	   fragile	   X	  syndrome	   (37).	   The	   molecular	   barcode	   consisted	   of	   a	   degenerate	   sequence	  absent	   of	   cytosine,	   since	   the	   identity	   would	   be	   ambiguous	   after	   bisulphite	  conversion.	   From	   the	   8	   samples	   in	   their	   study	   they	   identified	   redundant	  sequences	   ranging	   from	  7-­‐51%	  and	   that	  number	  appeared	   to	  be	   influenced	  by	  the	  amount	  of	  input	  DNA.	  	  	  
2.2	   DEVELOPMENT	  OF	  MOLECULAR	  BARCODING	  STRATEGIES	  	  Already	   in	   2004	   molecular	   barcoding	   of	   individual	   molecules	   had	   been	  theoretically	   explained	   and	   practically	   tested.	   Still	   the	   method	   didn’t	   get	  appreciated	  by	  a	  broader	  audience	  until	  2011.	  By	  then	  NGS	  was	  well	  established	  and	   this	   had	   accentuated	   the	   need	   for	   accurate	   quantification	   and	   error	  correction.	  	  	  
2.2.1	   Molecular	  barcoding	  for	  error	  correction	  
	  Casbon	   et	   al	   examined	   the	   performance	   of	   the	  molecular	   barcode	   (here	   called	  molecular	  counter)	  in	  amplicon	  sequencing	  (40)	  and	  showed	  that	  the	  molecular	  counter	  substantially	  lowered	  allelic	  bias,	  and	  could	  be	  used	  for	  error	  correction.	  They	   digested	   human	   genomic	   DNA	   with	   a	   restriction	   enzyme	   and	   ligated	  adapters	   containing	   random	   barcodes,	   here	   called	   degenerate	   base	   regions	  (DBR).	   Molecules	   were	   circularized,	   PCR	   amplified	   by	   inverse	   PCR	   and	  sequenced	  on	  the	  Roche	  454	  platform.	  	  To	  test	  the	  molecular	  counter,	  different	  amounts	  of	  input	  DNA	  were	  used	  in	  the	  inverse	   PCR	   reaction	   (50,	   100	   and	   250	   ng).	   Unsurprisingly	   there	   was	   no	  correlation	   between	   the	   number	   of	   reads	   and	   the	   input	  mass	   (R2	   =	   -­‐0.20),	   yet	  there	   was	   a	   correlation	   between	   input	   mass	   and	   the	   number	   of	   molecular	  counters	   (R2	   =	   0.78),	   showing	   that	   the	   counter	   was	   sensitive	   to	   an	   increased	  amount	   of	   input	   DNA.	  Most	   DBRs	   identified	  were	   singletons,	   which	   is	  when	   a	  molecular	   barcode	   is	   only	   supported	  by	   a	   single	   read,	   but	   some	  DBR	  had	  high	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read	   numbers,	   up	   to	   455	   reads	   for	   the	   50	   ng	   input	   sample,	   an	   indication	   of	  imbalanced	  amplification.	  	  	  Molecular	   barcoding	   is	   also	   useful	   for	   error	   correction.	   Most	   amplification-­‐induced	   errors	   occur	   in	   the	   later	   stages	   of	   amplification	   due	   to	   the	   increased	  number	  of	  DNA	  molecules	  present,	  allowing	  more	  opportunities	  for	  polymerase	  errors.	  Provided	  that	  a	  template	  molecule	  is	  sequenced	  to	  sufficient	  depth,	  these	  late-­‐occurring	  errors	  will	  constitute	  a	  minor	  part	  of	  all	  sequences	  with	  the	  same	  molecular	   barcode.	   By	   using	   a	   consensus	   nucleotide	   for	   each	   position	   in	   the	  template	  molecule	  such	  errors	  can	  be	  removed	  (shown	  in	  figure	  3).	  Casbon	  et	  al	  were	  able	  to	  show	  that	  by	  using	  a	  consensus	  read	  from	  molecular	  counters	  the	  error	   rate,	   in	   terms	   of	   artefactual	   mutations,	   insertions	   and	   deletions,	   was	  substantially	  lowered	  compared	  to	  using	  reads.	  	  	  Added	  to	  the	  study	  was	  a	  theoretical	  discussion	  about	  the	  likelihood	  of	  collision	  events.	   A	   collision	   occurs	   when	   two	   different	   identical	   molecules	   receives	   an	  identical	   barcode	   by	   chance.	   This	   is	  more	   likely	   to	   happen	   if	   the	   input	  DNA	   is	  limited	  and	   the	  number	  of	  bases	   in	   the	  degenerate	   sequence	  are	   few.	  Through	  the	  use	  of	  Bayes	  theorem	  the	  authors	  conclude	  that	  the	  number	  of	  collisions	  will	  be	   few	  when	   the	  number	  of	   template	  molecules	  are	   fewer	   than	  or	  equal	   to	   the	  square	  root	  of	  the	  number	  of	  possible	  combinations	  of	  the	  degenerate	  barcode.	  So	   if	   you	   expect	   to	   interrogate	  100	   identical	  molecules	   a	  molecular	  barcode	  of	  complexity	  10’000	  should	  be	  used,	  e.g.	  a	  degenerate	  barcode	  with	  the	  size	  of	  at	  least	  seven	  (4^7	  =	  16384).	  The	  authors	  also	  note	  that	  it	  is	  more	  important	  to	  get	  an	   exact	   quantification	   when	   the	   template	   molecules	   are	   few,	   i.e.	   it	   is	   more	  important	  to	  be	  able	  to	  quantify	  the	  difference	  between	  1	  and	  5	  molecules	  than	  between	  51	  and	  55.	  	  
2.2.2	   Redundant	  sequencing	  for	  improved	  error	  correction	  	  Redundant	  sequencing	  is	  important	  both	  to	  ensure	  that	  most	  or	  all	  molecules	  are	  sequenced	  and	   for	   allowing	   the	   creation	  of	   a	   consensus	   sequences.	  Kinde	   et	   al	  developed	   a	   molecular	   barcoding	   strategy	   where	   this	   was	   an	   important	  ingredient	   (41).	   Their	   method,	   called	   the	   Safe-­‐Sequencing	   System	   (Safe-­‐SeqS),	  comprised	   three	   steps:	   (i)	   assignment	   of	   a	   unique	   identifier	   (UID),	   (ii)	  amplification	   of	   each	   uniquely	   tagged	   template	   to	   create	   UID	   families,	   (iii)	  redundant	  sequencing	  of	  the	  amplification	  products.	  Safe-­‐SeqS	  had	  a	  read	  depth	  averaging	  15-­‐107	  reads	  per	  molecule	  and	  used	  a	  minimum	  2	  reads	  to	  construct	  a	  consensus	  sequence.	  Examined	  mutations	  on	  PCR	  fragments	  with	  the	  same	  UID	  were	  considered	  a	   true	  mutation	  only	   if	  more	   than	  95%	  of	   them	  contained	  the	  identical	  mutation,	  here	  called	  a	  supermutant.	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Figure	  3:	  Molecular	  barcoding	  of	  individual	  molecules	  for	  error	  correction.	  	  Molecular	  barcodes	  can	  be	  used	  to	  correct	  for	  amplification	  or	  sequencing	  induced	  errors.	  A	  true	  mutation	  should	  be	  present	  in	  all	  or	  most	  copies	  in	  a	  group	  of	  molecules	  with	  the	  same	  barcode.	  Amplification-­‐induced	  errors	  are	  more	  common	   in	   the	   later	   stages	  of	  PCR	  and	  each	  such	  error	  normally	  constitutes	  a	  minority	  of	  all	  molecules	  with	  identical	  barcodes.	  	  In	   Safe-­‐Seqs	   genomic	   DNA	   amplicon	   targets	   were	   amplified	   two	   cycles	   with	  amplicon-­‐specific	   primers	   where	   both	   primers	   contained	   a	   universal	   tag	  sequence	   and	   the	   forward	   primer	   contained	   a	   random	   barcode	   of	   12-­‐14	  nucleotides.	   The	   tagged	   templates	  were	   then	   amplified	   an	   additional	   25	   round	  with	  primers	  hybridizing	  to	  the	  universal	  sequences	  and	  then	  sequenced	  on	  an	  Illumina	  GA	  IIx	  instrument.	  	  Safe-­‐SeqS	  was	  applied	  to	  study	  the	  prevalence	  of	  rare	  mutations	  in	  a	  small	  region	  of	  the	  CTNNB1	  gene	  isolated	  from	  ~100’000	  humans	  cells	  from	  three	  unrelated	  individuals.	  Conventional	  analysis	  of	  Illumina	  sequencing	  resulted	  in	  a	  mutation	  rate	  of	  around	  2×10-­‐4	  mutations	  per	  bp.	  Safe-­‐Seqs	  however	  had	  a	  mutation	  rate	  of	  9×10-­‐6	  mutations	  per	  bp,	  reducing	  the	  frequency	  of	  mutations	  in	  genomic	  DNA	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24-­‐fold,	   confirming	   that	   most	   mutations	   identified	   without	   the	   molecular	  barcode	  were	  artefactual.	  	  Kinde	  et	  al	  made	  a	  contribution	  to	  the	  use	  of	  molecular	  barcodes	  by	  introducing	  the	  concept	  of	  endogenous	  versus	  exogenous	  barcodes.	  An	  exogenous	  barcode	  is	  a	  barcode	  that	  is	  added	  to	  the	  molecule	  of	  interest	  e.g.	  through	  adaptor	  ligation	  or	  limited	  cycles	  of	  PCR	  during	  library	  preparation.	  The	  exogenous	  barcode	  can	  in	  principle	  be	  made	  to	  contain	  an	  unlimited	  number	  of	  different	  barcodes.	  If	  the	  barcode	  contains	  any	  of	   the	  A,	  C,	  G	  or	  T	  bases	  then	  the	   limit	   is	   in	  how	  long	  the	  sequence	  is	  and	  the	  number	  of	  possible	  barcodes	  will	  be	  4N.	  Kinde	  et	  al	  realised	  that	  it	  was	  possible	  to	  use	  the	  ends	  of	  molecules	  that	  had	  been	  randomly	  sheared	  as	  the	  UID	  (illustrated	  in	  figure	  4).	  If	  shearing	  occurs	  randomly	  it	  is	  unlikely	  that	  a	   fragment	   will	   have	   the	   exact	   5’	   and	   3’	   end	   as	   another	   fragment.	   This	  endogenous	  UID	  doesn’t	  require	  an	  externally	  added	  barcode,	  but	  has	  a	   limited	  number	   of	   unique	   ID’s,	   and	   is	   suitable	  when	   the	   number	   of	   targets	   is	   limited.	  Here	  Kinde	  et	  al	   showed	   that	   it	  was	  possible	   to	  use	   the	  endogenous	  UID	  when	  studying	  DNA	  mutations	  from	  around	  15’000	  cells.	  	  	  
2.2.3	   Mutational	  hotspots	  to	  further	  reduce	  errors	  	  Building	   on	   to	   the	   approach	   taken	   by	   Kinde	   et	   al,	   Shugay	   et	   al	   developed	   a	  method	  to	  further	  reduce	  artefactual	  mutations	  (50),	  named	  Molecular	  Identifier	  Groups-­‐based	  Error	  Correction	  (MIGEC).	  	  	  MIGEC	  exploits	   the	  phenomenon	   that	  most	  artefactual	  mutations	  are	  produced	  in	   the	   later	  stages	  of	  PCR	  amplification	  and	  are	   therefore	   filtered	  out	  when	  the	  consensus	   sequence	   is	   constructed.	   The	   artefactual	   mutations	   are	   often	  reproducible	  and	  Shugay	  et	   al	   showed	   that	   for	  a	   specific	   sequence	  >90%	  of	  all	  errors	   were	   reproducible	   and	   therefore	   mutational	   “hotspots”	   could	   be	  identified,	   as	   shown	   in	   figure	   5.	   On	   top	   of	   error	   correction	   based	   on	   the	  consensus	  sequence,	  in	  MIGEC	  these	  mutational	  hotspots	  are	  also	  filtered	  out.	  	  	  It	   was	   also	   observed	   that	   due	   to	   amplification-­‐induced	   errors	   within	   the	   UMI	  sequence	   itself,	   the	   amount	   of	   UMIs	   was	   inflated	   (51).	   A	   12	   bp	   long	   UMI	  amplified	   and	   sequenced	   104	   times	   often	   resulted	   in	   10-­‐20	   erroneous	   UMI	  subvariants	   due	   to	  mutations	   in	   the	  UMI	   sequence.	   If	   no	   correction	  was	  made	  this	  would	   result	   in	   an	   estimation	   of	   11-­‐21	   template	  molecules	  when	   the	   true	  number	   of	   molecules	   was	   1.	   Since	   most	   UMI	   errors	   are	   created	   by	   a	   single	  mismatch	   from	   the	   true	   UMI	   and	   have	   a	   low	   read	   coverage,	   a	   two	   stage	   UMI	  filtering	   approach	   was	   applied	   in	   MIGEC	   where	   minor	   UMI	   subvariants	   that	  differed	  by	  a	  single	  nucleotide	  were	  removed	  and	  then	  a	  threshold	  was	  set	  of	  at	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least	  several	  sequencing	  reads	  per	  UMI.	  The	  optimal	  threshold	  varied	  depending	  on	  the	  size	  of	  the	  starting	  library	  and	  the	  level	  of	  over-­‐sequencing	  achieved.	  	  	  
	  
Figure	  4:	  Endogenous	  barcodes	  Barcodes	   can	   be	   prepared	   by	   random	   shearing	   of	   DNA	   or	   RNA.	   If	   molecules	   are	   sufficiently	  diluted	  and	  randomly	  sheared	  each	  molecule	  will	  have	  a	  unique	  start	  and/or	  end	  position	  in	  the	  genome,	   and	   is	   therefore	  unique	  with	  a	  high	  probability	   in	   a	   similar	  manner	  as	   the	  exogenous	  barcode.	  	  
2.2.4	   Error	  correction	  by	  the	  complementary	  strand	  to	  remove	  artefacts	  from	  the	  
first	  round	  of	  amplification	  	  The	   methods	   described	   above	   all	   show	   remarkable	   abilities	   to	   reduce	  amplification	   and	   sequencing	   induced	   errors.	   But	   none	   of	   them	   were	   able	   to	  handle	  errors	   introduced	   in	   the	   first	   round	  of	  amplification.	  MIGEC	  can	  correct	  for	  hotspot	  mutational	  errors	   in	   the	   first	  round	  of	  amplification,	  but	  not	  errors	  coming	  from	  some	  other	  sources.	  Therefore	  a	  certain	  uncertainty	  existed	  about	  how	  prevalent	  these	  errors	  were.	  	  
Each fragment has a 
unique set of 5’ and 3’ 
end positions in the 
genome 
Shear DNA (or RNA)
Amplify and sequence
Remove copies of 
identical molecules
Endogenous barcodes
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  To	  correct	  such	  errors	  a	  new	  method	  was	  developed	  called	  Duplex	  Sequencing.	  It	  reduces	   artefactual	   amplification-­‐induced	   mutations	   by	   using	   the	   double-­‐stranded	  nature	  of	  DNA	  for	  error	  correction	  (43).	   If	  a	  mutation	  arises	   it	  should	  arise	  in	  both	  strands,	  and	  if	  both	  strands	  are	  sequenced	  then	  the	  mutation	  should	  exist	   in	   both	   strands	   in	   the	   sequencing	   data,	   otherwise	   the	   mutation	   is	   an	  artefact.	  A	  benefit	  of	  this	  method	  is	  that	  it	  captures	  errors	  also	  in	  the	  first	  round	  of	   amplification,	   which	   frequently	   happens	   when	   the	   DNA	   is	   damaged	   or	  degraded.	  Schmitt	  et	  al	  argues	  that	  since	  the	  mutation	  rate	  during	  cell	  division	  is	  estimated	   to	   range	   from	   10-­‐8	   to	   10-­‐11	   per	   nucleotide,	   the	   majority	   of	   the	  mutations	   called	   with	   the	   previously	   mentioned	   error	   reduction	  methods	   still	  potentially	  represent	  technical	  artefacts.	  Also,	  commonly	  used	  DNA	  polymerases	  for	   library	   construction	   have	   a	   misinsertion	   frequency	   rate	   between	   10−4	   and	  10−6	   (52),	   which	   leads	   to	   many	   false	   positives	   even	   in	   the	   first	   round	   of	   PCR	  amplification.	   In	   order	   for	   Duplex	   Sequencing	   to	   interpret	   an	   artefactual	  mutation	   as	   a	   “true”	   mutation,	   the	   complementary	   artefactual	   mutation	   must	  occur	  on	  the	  complementary	  strand	  as	  well,	  which	  is	  a	  very	  unlikely	  event.	  	  In	   Duplex	   Sequencing,	   adapters	   are	   created	   by	   two	   partially	   complementary	  oligonucleotides,	  one	  of	  which	  has	  a	  12	  bp	  degenerate	  overhang.	  The	  overhang	  was	  rendered	  double	  stranded	  by	  a	  DNA	  polymerase	  and	  then	  adapter	  A-­‐tailing	  was	  performed	  by	   incubation	  of	   the	   adaptors	  with	  DNA	  polymerase	   and	  dATP	  (Deoxyadenosine	   triphosphate).	   Genomic	   DNA	   is	   prepared	   with	   shearing	   and	  end-­‐repair	   by	   standard	   protocols.	   A	   T-­‐overhang	   is	   created	   by	   polymerase	  elongation	  of	  template	  DNA	  with	  dTTP	  (Deoxythymidine	  triphosphate).	  Adapters	  are	  ligated	  to	  the	  template	  and	  the	  product	  is	  PCR	  amplified	  and	  sequenced	  with	  paired-­‐end	   sequencing.	   Reads	   are	   grouped	   based	   on	   the	   UMI	   and	   consensus	  sequences	   are	   created.	   Thereafter	   complementary	   sequences	   are	   identified	  based	   on	   the	  UMI.	   Since	   both	   ends	   of	   the	   template	  molecule	   have	   a	  UMI,	   both	  ends	   must	   match	   to	   call	   a	   complementary	   pair.	   After	   successful	   pairing	   the	  template	   sequences	   are	   compared	   and	   only	   bases	  matching	   perfectly	   are	   kept	  and	  called	  duplex	  consensus	  sequences	  (DCSs)	  as	  illustrated	  in	  figure	  6.	  	  To	   test	   Duplex	   Sequencing	  M13mp2	   DNA,	   a	   substrate	   extensively	   studied	   and	  that	  has	  a	  well-­‐established	  base	  substitution	  frequency	  of	  3*10-­‐6,	  was	  sequenced.	  Standard	   analysis	  methods	   including	   quality	   filtering	   for	   a	   Phred	   score	   higher	  than	  30	  resulted	   in	  an	  error	   frequency	  of	  3.8*10-­‐3,	  more	   than	  1000-­‐fold	  higher	  than	  the	  true	  mutation	  frequency.	  Consensus	  filtering	  based	  on	  the	  UMI	  resulted	  in	   an	   error	   frequency	   of	   3.4*10-­‐5,	   suggesting	   it	   corrected	   for	   99%	   of	   all	  sequencing	   errors.	   Still	   this	   number	   was	   >	   10-­‐fold	   higher	   than	   the	   reference	  value.	  When	   Duplex	   Sequencing	   analysis	   was	   applied,	   the	  mutation	   frequency	  went	  down	  to	  2.5*10-­‐6,	  almost	  identical	  to	  the	  reference	  value	  of	  3*10-­‐6.	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Figure	  5:	  Mutational	  “hotspot”	  correction	  of	  errors	  	  A)	   Possible	   scenarios	   of	   error	   distribution	   among	   reads	   with	   the	   same	   barcode.	   B)	   Early	  amplification-­‐induced	  error	  rarely	  dominates	  the	  read	  family.	  Late	  amplification-­‐induced	  errors	  are	   comparatively	   common,	   and	   often	   occurs	   at	   the	   same	   position	   between	   different	   read	  families	   of	   the	   identical	  molecules.	   This	   can	   be	   used	   to	   identify	   and	   correct	   early	   polymerase	  errors.	   Correct	   subclones	   always	   gain	   reads	   after	   the	   first	   correction,	   while	   subclones	   with	   a	  repetitive	  PCR	  error	  lose	  reads.	  In	  this	  example	  the	  correct	  subclone	  gained	  5	  reads	  (32-­‐27)	  and	  the	   erroneous	   one	   lost	   5	   reads	   (13-­‐8).	   The	   position	   was	   therefore	   identified	   as	   a	   mutational	  hotspot	  and	  was	  corrected	  in	  the	  second	  round	  of	  correction.	  MIG	  –	  Molecular	  Identifier	  Group.	  Adapted	  from	  Shugay	  et	  al	  (2014).	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Figure	  6:	  Using	  the	  complementary	  strand	  to	  correct	  for	  errors	  –	  Duplex	  Sequencing	  Three	  examples	  of	  read	  groups	  with	   the	  same	  molecular	  barcode	  are	  shown.	  The	   first	  example	  shows	   a	   read	   group	   with	   a	   random	   mutation	   in	   one	   strand,	   which	   is	   interpreted	   as	   a	   false	  mutation.	  The	  second	  example	  shows	  a	  mutation	  that	   is	  consistent	  on	  one	  strand,	  but	   is	  absent	  on	   the	  other;	   this	   in	   interpreted	  as	  an	  artefactual	   copy	  of	   the	  nucleotide,	  probably	  due	   to	  DNA	  damage.	  The	  third	  example	  shows	  that	  a	  true	  mutation	  must	  exist	  in	  both	  strands.	  Adapted	  from	  Schmitt	  et	  al	  (2012).	  	  Interestingly,	   errors	   not	   corrected	   for	   by	   duplex	   consensus	   building	   had	   a	  specific	   mutational	   pattern	   with	   an	   excess	   of	   	   C→T	   and	   G→T	   relative	   to	   the	  reference.	  G→T	  mutations	   can	  be	   explained	  by	   the	   fact	   that	   an	  A	   is	   commonly	  inserted	  opposite	  to	  8-­‐oxo-­‐G	  leading	  to	  misinterpretation	  of	  G	  as	  a	  T.	  The	  G→T	  was	  also	   in	  great	  excess	  of	   the	  C→A	  mutation,	  which	   if	  all	  mutations	  had	  been	  correct,	  would	   have	   had	   the	   same	   frequency.	   The	   C→T	  mutation	   is	   consistent	  with	  a	  spontaneous	  deamination	  of	  cytosine	  to	  uracil,	  also	  leading	  to	  insertion	  of	  adenine	   opposite	   to	   the	   uracil	   and	   a	   misinterpretation	   of	   C	   as	   a	   T.	   These	  artefactual	  mutations	  were	  not	  seen	  in	  the	  Duplex	  Sequencing	  corrected	  data.	  	  	  






















Schmitt	  et	  al	  suggested	  that	  the	  difference	  in	  mutation	  frequencies	  between	  the	  UMI	  method	  and	  the	  Duplex	  Sequencing	  method	  could	  be	  exploited	  to	  study	  the	  extent	  of	  oxidative	  DNA	  damage	   in	  a	   sample.	  Duplex	  Sequencing	  has	  also	  been	  used	   to	   estimate	   the	  mutational	   frequency	   of	   human	  brain	  mitochondrial	  DNA	  (53),	   and	   it	   was	   used	   to	   detect	   rare	   mutations	   in	   the	   ABL1	   gene	   that	   confer	  resistance	  to	  imatinib	  when	  treating	  chronic	  myeloid	  leukaemia	  (54)	  	  
2.2.5	   Error	  tolerant	  barcode	  set	  to	  account	  for	  UMI	  mutations	  	  Making	  the	  molecular	  barcode	  degenerate	  is	  a	  convenient	  way	  of	  preparing	  and	  handling	   the	  adaptor	  or	  primer	  –	  you	  only	  need	  one	  barcode.	  However	   library	  preparation	  easily	  introduces	  errors	  to	  the	  barcode	  leading	  to	  the	  introduction	  of	  artefactual	  unique	  molecules,	  and	  at	  least	  some,	  if	  not	  all,	  of	  the	  singleton	  UMIs	  can	  be	  attributed	  to	  this.	  To	  overcome	  this	  problem	  a	  method	  was	  invented	  that	  use	  a	  pre-­‐determined	  set	  of	  barcodes	  to	  replace	  the	  degenerate	  barcode.	  The	  set	  consisted	  of	  145	  barcode	  sequences	  20	  bp	  long,	  designed	  in	  such	  a	  way	  that	  each	  barcode	   had	   a	   Hamming	   distance	   of	   4,	   that	   is	   they	   could	   sustain	   up	   to	   four	  substitution	   errors	   and	   still	   be	  unambiguously	   identifiable	   (55).	   The	  benefit	   of	  this	   is	   illustrated	   in	   figure	  7.	  To	   increase	  the	  number	  of	   labels	  the	  barcode	  was	  attached	  to	  each	  end	  of	   the	  template	  molecule	  and	  then	  paired-­‐end	  sequencing	  was	   used	   to	   identify	   both	   molecular	   barcodes.	   In	   this	   way	   145*145	   =	   21,025	  unique	  labels	  was	  be	  created.	  This	  also	  has	  the	  added	  benefit	  that	  if	  one	  end	  had	  a	  strong	  bias	  towards	  a	  certain	  barcode,	   the	  other	  end	   is	  unlikely	  to	  be	  equally	  biased.	  	  Shiroguchi	   et	   al	   tested	   the	   improved	   barcoding	   strategy	   on	   a	   set	   of	   spike-­‐in	  molecules	  where	   one	   sample	  was	   labelled	  with	   a	   degenerate	   barcode	   and	   one	  sample	   was	   labelled	   with	   the	   pre-­‐determined	   barcodes.	   The	   comparison	  between	   the	   two	   barcoding	   strategies,	   with	   a	   degenerate	   barcode	   16	   bp	   long,	  showed	  that	  the	  degenerate	  barcode	  produced	  an	  estimate	  of	  pre-­‐PCR	  molecules	  15.5-­‐fold	  higher	  than	  the	  estimated	  input	  of	  10’000	  molecules.	  A	  large	  part	  of	  the	  degenerate	  barcode	  estimation	  came	  from	  barcodes	  with	  a	  low	  read-­‐count.	  The	  over-­‐estimation	   using	   degenerate	   barcodes	  was	   lowered	   to	   2.4	   fold	   under	   the	  assumption	  that	  two	  molecules	  with	  up	  to	  two	  mismatches	  in	  the	  barcode	  region	  were	  originally	  from	  the	  same	  DNA	  molecule.	  	  	  Interestingly	   the	   predetermined	   set	   of	   barcodes	   had	   very	   few	  barcodes	  with	   a	  low	  number	  of	  reads	  indicating	  that	  a	  large	  part	  of	  degenerate	  barcodes	  with	  few	  reads	   are	   artefacts	   created	   during	   amplification	   and	   sequencing.	   The	  predetermined	  set	  of	  barcodes	  underestimated	  the	  number	  of	  molecules	  by	  0.5	  fold.	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Figure	  7:	  Error	  tolerant	  barcode	  set	  to	  identify	  and	  correct	  for	  UMI	  mutations	  A	  defined	  barcode	  set	  is	  tolerant	  to	  a	  certain	  number	  of	  substitution	  mutations.	  Here	  a	  simplified	  illustration	  is	  shown	  with	  only	  two	  types	  of	  nucleotides	  instead	  of	  four.	  To	  the	  left,	  two	  barcodes	  with	  a	  Hamming	  distance	  of	  4.	  When	  a	  mutation	  occurs	  in	  such	  a	  barcode	  it	  is	  still	  possible	  to	  tell	  which	  barcode	  the	  mutated	  barcode	  belonged	  to,	  since	  it	  will	  be	  more	  similar	  to	  that	  barcode	  than	  to	  any	  other	  barcode.	  To	  the	  right,	  a	  random	  barcodes	  where	  two	  molecular	  barcodes	  by	  chance	  got	  a	  Hamming	  distance	  of	  2.	  In	  this	  case	  a	  single	  mutation	  can	  make	  it	  impossible	  to	  infer	  which	  original	  barcode	  the	  mutated	  barcode	  belonged	  to.	  In	  reality	  only	  the	  information	  after	  amplification	  and	  sequencing	  is	  known	  and	  in	  this	  case	  the	  barcode	  sequences	  on	  the	  right	  could	  be	  interpreted	  as	  representing	  1-­‐6	  template	  molecules	  depending	  on	  how	  stringent	  the	  barcode	  consensus	  criteria	  is	  set.	  	  
2.2.6	   Creating	  limiting	  dilution	  using	  primers	  instead	  of	  template	  	  Individual	  UMIs	  should	  preferentially	  be	  sequenced	  multiple	  times	  both	  in	  order	  to	   facilitate	  an	  accurate	  error	  correction,	  and	  to	  be	  confident	  that	  all	   individual	  molecules	  have	  been	  detected.	   In	  many	  applications	   this	  requires	   that	   the	  DNA	  from	   each	   sample	   is	   diluted	   before	   applying	   adaptors	   or	   primers.	   It	   is	   both	  cumbersome	   to	  measure	   the	  DNA	   concentration	   of	   each	   sample,	   and	   it	   can	   be	  difficult	   to	  make	  each	  sample	  equally	  diluted,	  creating	  a	  bias	  between	  samples.	  Faith	  et	  al	  suggests	  a	  method,	  Low-­‐Error	  Amplicon	  Sequencing	  (LEA-­‐Seq)	  (56),	  to	  circumvent	  this	  problem:	  Instead	  of	  creating	  a	  limited	  dilution	  of	  the	  samples,	  the	  PCR	  primers	  in	  a	  first	  round	  of	  PCR	  are	  diluted,	  as	  illustrated	  in	  figure	  8.	  This	  set	  of	  diluted	  PCR	  primers	  can	  then	  be	  used	  on	  all	  samples.	  	  	  	  	  




























Figure	  8:	  Using	  primers	  as	  limiting	  dilution.	  Comparison	  between	   a	   standard	  barcoding	   approach	   to	   the	   left	  where	   template	  molecules	   are	  diluted	  before	  barcoding	  and	  an	  excess	  of	  barcodes	  are	  used,	  and	  the	  limiting	  dilution	  of	  primers	  approach	   to	   the	   right,	  where	   the	  number	  of	   primers	   are	  diluted	  before	   the	  barcoding	   reaction	  and	  the	  number	  of	  template	  molecules	  are	  left	  intact.	  	  
2.2.7	   Singleton	  UMI	  molecules	  	  A	   general	   problem	  with	  molecular	   barcoding	   is	   that	   often	   a	   surprisingly	   large	  part	   of	   all	   molecules	   are	   singletons.	   This	   is	   due	   to	   mutations	   in	   the	   UMI	  sequences	   or	   that	   the	   library	   is	   not	   sequenced	   deep	   enough	   in	   relation	   to	   its	  complexity.	  The	  latter	  can	  be	  resolved	  by	  sequencing	  deeper,	  while	  the	  former	  is	  harder	  to	  work	  around.	  If	  a	  predefined	  set	  of	  barcodes	  is	  used	  then	  mutations	  in	  the	  UMI	  is	  a	  rather	  straightforward	  problem	  to	  solve,	  but	  in	  many	  applications	  a	  degenerate	  sequence	  is	  used.	  	  	  At	  least	  two	  strategies	  have	  been	  proposed	  to	  handle	  singletons:	  either	  they	  are	  removed,	   which	   can	   lead	   to	   substantial	   loss	   of	   data,	   or	   molecules	   with	   very	  similar	  UMI	  sequences	  are	  grouped	  together	  (51),	  which	  potentially	  leads	  to	  an	  underestimation	   of	   the	   true	   number	   of	   UMI.	   Lundberg	   et	   al	   proposed	   a	   third	  method	   to	   deal	   with	   singletons	   (57).	   They	   noted	   that	   in	   template-­‐overloaded	  samples,	  that	  is	  samples	  with	  few	  reads	  per	  barcode	  in	  average,	  more	  singletons	  will	  be	  correct	  compared	  to	   libraries	  with	  a	  high	  ratio	  of	  reads	  per	  barcode,	  as	  shown	   in	   figure	   9.	   In	   their	   study	   sequencing	   reads	   were	   either	   analysed	   as	  
Standard Barcoding Approach Limiting Dilution of Primers
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untreated	  (non-­‐consensus),	  as	  consensus	  sequences,	  or	  as	  Consensus	  sequences	  plus	   Adjusted	   Singletons	   (CASs),	   where	   singletons	   were	   downsampled	   in	  proportion	  to	  reads	  per	  molecular	  barcode.	  	  	  
Figure	  9:	  Singleton	  UMI	  sequences	  	  On	  the	  left	  hand	  side	  few	  molecules	  are	  highly	  amplified	  and	  sequenced.	  Since	  each	  molecule	  is	  sequenced	  several	  times,	  most	  singletons	  are	  due	  to	  amplification	  or	  sequencing	  induced	  errors,	  either	  in	  the	  barcode	  or	  the	  template.	  However	  if	  the	  library	  isn’t	  over	  sequenced,	  many	  non-­‐mutant	  singleton	  molecules	  will	  also	  be	  detected.	  	  	  	  	   	  
Set of identical molecules pre PCR
Introduce a molecular barcode to 
make each molecule unique
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2.3	   APPLICATIONS	  OF	  MOLECULAR	  BARCODING	  	  Apart	   from	   the	   experiments	   explained	   above	   the	   barcoding	   strategy	   has	   been	  used	  in	  many	  other	  applications.	  Some	  of	  these	  are	  discussed	  below	  to	  indicate	  the	  general	  applicability	  of	  the	  method.	  	  	  
2.3.1	   Exact	  quantification	  of	  genomic	  copy	  number	  variation	  
	  Molecular	  barcoding	  of	   individual	  molecules	  have	  been	  applied	   to	  determining	  chromosomal	  copy	  number	  variation	  either	  with	  a	  fixed	  set	  of	  barcodes	  (49)	  or	  by	  endogenous	  barcodes	  and	  limiting	  dilution	  (34).	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figure	   10,	   which	   shows	   that	   molecule	   counting	   reduces	   noise	   and	   is	   more	  suitable	  to	  identify	  the	  extra	  copy	  at	  chromosome	  21.	  	  	  







Figure	  11:	  UMIs	  reduce	  noise	  in	  single-­‐cell	  RNA-­‐seq	  Spike-­‐in	  molecules	  can	  be	  used	  to	  model	  technical	  variability.	  If	  they	  are	  added	  in	  the	  same	  concentration	  to	  each	  cell	  before	  library	  preparation	  they	  can	  be	  used	  as	  a	  proxy	  for	  technical	  variation.	  Genes	  are	  shown	  in	  blue	  and	  spike-­‐in	  molecules	  in	  pink.	  The	  pink	  line	  is	  a	  line	  fitted	  to	  the	  spike-­‐in	  molecules.	  Data	  is	  taken	  from	  (63).	  On	  the	  left,	  expression	  was	  measured	  in	  molecule	  counts	  (i.e.	  UMIs).	  On	  the	  right,	  expression	  was	  measured	  in	  read	  counts.	  Using	  UMIs	  reduced	  technical	  noise,	  and	  enabled	  detection	  of	  true	  biological	  variability	  in	  a	  greater	  number	  of	  genes.	  
	  
2.3.3	   Assessment	  of	  efficiency	  in	  library	  preparation	  
	  Fu	  et	  al	  used	  molecular	  barcoding	   to	  assess	   the	  efficiency	  of	   standard	   Illumina	  library	   preparation	   for	   RNA	   sequencing	   and	   concluded	   that	   for	   every	   1000	  copies	  of	   a	   transcript	   in	   the	   starting	   sample	  only	  1-­‐6	   copies,	  depending	  on	   the	  ERCC	  molecule	   used	   in	   the	   measurement,	   remained	   in	   the	   sequencing	   library	  (64).	  In	  the	  same	  study	  they	  also	  showed	  that	  it	  isn’t	  enough	  to	  just	  use	  the	  start	  and	   end	   position	   of	   a	   randomly	   fragmented	   RNA	   molecule	   as	   an	   endogenous	  barcode	   since	   the	   fragmentation	   (or	   random	  priming	  or	   reverse	   transcription)	  isn’t	  truly	  random.	  There	  are	  many	  more	  molecules	  with	  identical	  start	  and	  end	  positions	   than	  would	   be	   expected	   if	   the	   break	   point	   would	   assume	   a	   uniform	  distribution.	  	  The	  molecular	  barcoding	  strategy	  has	  also	  been	  put	  into	  practice	  for	  example	  in	  RNA-­‐proteins	   interactions	  using	   the	  UV	   cross-­‐linking	  and	   immunoprecipitation	  (iCLIP)	  method	  (39),	  and	  in	  lineage	  tracing	  (65,	  66).	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2.4	   AN	  ALTERNATIVE	  METHOD	  TO	  CORRECT	  FOR	  ERRORS	  
	  If	   input	  material	   is	   plenty	   an	   alternative	   to	   error	   correction	   with	   a	   barcoding	  strategy	   would	   be	   to	   prepare	   a	   library	   without	   amplification.	   Such	   a	   library	  would	  per	  definition	  not	  contain	  any	  amplification-­‐induced	  errors,	  but	   it	  would	  still	  be	  prone	  to	  other	  errors	  created	  during	  the	  library	  preparation.	  	  	  
	  
Figure	  12:	  Circle	  sequencing	  to	  correct	  for	  errors	  	  A	  major	  difference	  between	  traditional	  barcoding,	  shown	  to	  the	  left,	  and	  circle	  sequencing,	  shown	  to	  the	  right,	  is	  that	  traditional	  barcoding	  in	  combination	  with	  PCR	  amplification	  leads	  to	  both	  clonal	  and	  random	  errors,	  where	  circle	  sequencing	  only	  has	  random	  errors.	  Adapted	  from	  Lou	  et	  al	  (2013).	  	  Lou	   et	   al	   proposed	   an	   alternative	   method,	   Circle	   Sequencing,	   to	   correct	   for	  library	  preparation	  and	  sequencing	  errors	  (67).	  Instead	  of	  making	  each	  molecule	  unique,	   the	   library	  was	   size-­‐selected	   to	   contain	   only	  molecules	   around	   1/3	   of	  expected	   sequencing	   length.	   Molecules	   were	   then	   circularized	   and	   amplified	  with	  rolling	  circle	  amplification	  (RCA)	  before	  sequencing	  as	  shown	  in	  figure	  12.	  
















A	  major	  benefit	  using	  RCA	  is	  that	  artefactual	  mutations	  in	  the	  copy	  aren’t	  clonally	  expanded,	  as	  is	  the	  case	  of	  mutations	  introduced	  by	  PCR.	  Instead	  mutations	  are	  randomly	  introduced	  and	  are	  therefore	  easy	  to	  correct	  for.	  In	  contrast	  to	  Duplex	  Sequencing,	  damaged	  DNA	  may	  still	  propagate	  errors.	  These	  errors	  are	  reduced	  in	   Circle	   Sequencing	   by	   treatment	   of	   DNA	   with	   uracil-­‐DNA	   glycosylase	   and	  formamidopyrimidine-­‐DNA	   glycosylase,	   which	   excise	   deaminated	   cytosine	   and	  8-­‐oxo-­‐guanine	   bases,	   prior	   to	   library	   preparation.	   This	   treatment	   reduced	   the	  error	   rate	   by	   more	   than	   one	   order	   of	   magnitude	   and	   should	   be	   applicable	   in	  other	  molecular	  barcoding	  or	  library	  preparation	  protocols	  too.	  	  
	  Importantly	   yield,	   defined	  as	   the	   total	  number	  of	  high-­‐quality	   consensus	  bases	  produced	   divided	   by	   the	   raw	   number	   of	   sequenced	   bases	   was	   substantially	  higher	  for	  Circle	  Sequencing	  compared	  to	  any	  other	  barcoding	  method.	  Standard	  UMI	  barcoding	  methods	  are	  sensitive	  to	  the	  amount	  of	  input	  material	  used:	  low	  amount	   of	   input	  material	   compared	   to	   sequencing	   depth	   results	   in	   redundant	  information,	  while	  a	  high	  amount	  of	   input	  material	  will	   give	   too	   few	  reads	  per	  barcode	   to	   build	   a	   consensus	   sequence.	   In	   contrast	   in	   Circle	   Sequencing	   the	  repeats	  are	  linked,	  and	  therefore	  reads	  per	  barcode	  will	  be	  the	  same	  regardless	  of	   the	   number	   of	   input	   molecules.	   It	   was	   noted	   however	   that	   for	   some	  applications	   a	   PCR	   amplification	   step	   might	   be	   necessary	   before	   Circle	  Sequencing,	  and	  in	  those	  cases	  Circle	  Sequencing	  will	  not	  be	  able	  to	  account	  for	  mutations	  acquired	  before	  circularization.	  	  
	  
2.5	   AN	  ALTERNATIVE	  METHOD	  TO	  CREATE	  UNIQUE	  SEQUENCES	  
	  So	   far	   two	  methods	   have	   been	   proposed	   to	   make	   identical	   molecules	   unique:	  endogenous	   and	   exogenous	   barcoding.	   In	   these	   two	   methods	   the	   barcode	   is	  placed	  at	  the	  end	  of	  the	  molecule	  allowing	  only	  sequences	  to	  be	  identified	  within	  one	   read	   length	   from	   the	   end.	   This	   creates	   a	   problem	   e.g.	   in	   mRNA	   isoform	  determination	   using	   short	   read	   assembly.	   It	   is	   possible	   to	   first	   fragment	   the	  mRNA	  and	  then	  add	  the	  UMI,	  however	  this	  would	  resort	  to	  a	  probabilistic	  model	  of	   isoform	   usage	   since	   the	   information	   of	   long-­‐range	   exon	   connectivity	   is	   lost.	  Recently	  a	  paper	  was	  published	  that	  proposed	  a	  way	  to	  make	  molecules	  unique	  by	   exploiting	   incomplete	   bisulphite	   conversion	   of	   cDNA,	   leading	   to	   restricted	  random	  mutation	  before	  amplification	  (68).	  The	  idea	  is	  illustrated	  in	  figure	  13.	  	  	  The	   authors	   created	   a	   model	   where	   they	   varied	   the	   number	   of	   C	   residues,	  coverage	   per	   template,	   and	   conversion	   rate	   of	   C	   to	   T	   for	   reads	  with	   length	   of	  2*100	  bp.	  They	  concluded	  that	   it	  was	  enough	  with	  30C	  residues	  and	  a	   flip	  rate	  0.35	  to	  make	  more	  than	  thousands	  of	  identical	  molecules	  unique.	  This	  assembly	  by	  mutagenesis	  would	  be	  beneficial	  not	  only	   in	   isoform	  determination	  but	  also	  for	  discrimination	  of	  haplotypes	  and	  de	  novo	  haplotype	  assembly.	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Figure	  13:	  Template	  mutagenesis	  to	  make	  molecules	  unique	  Identical	  templates	  can	  be	  made	  unique	  by	  exposing	  them	  to	  a	  mutation-­‐inducing	  agent	  that	  mutates	  specific	  sites	  with	  a	  certain	  flip	  rate.	  Templates	  can	  then	  be	  amplified,	  fragmented	  and	  sequenced.	  After	  sequencing	  it	  is	  possible	  to	  both	  quantify	  the	  number	  of	  input	  template	  molecules	  and	  to	  stich	  the	  short	  reads	  together	  to	  re-­‐create	  the	  long	  template	  molecule.	  	  
2.6	   CONCLUSIONS	  PART	  2	  	  Molecular	   barcoding	   of	   individual	   molecules	   has	   been	   shown	   to	   increase	  quantification	   and	   reproducibility,	   reduce	   noise	   and	   lower	   the	   substitution,	  insertions	   and	   deletion	   errors	   produced	   by	   sequencing	   and	   amplification.	  Molecular	  barcoding	  has	  been	  used	  in	  many	  applications	  including	  sequencing	  of	  gut	   bacteria,	   lineage	   tracing	   and	   estimation	   of	   polymerase	   fidelity	   and	   in	   a	  number	   of	   different	   sequencing	   settings,	   like	   amplicon	   sequencing,	   DNA	  sequencing	  from	  a	  genomic	  region,	  and	  in	  single-­‐cell	  RNA	  sequencing.	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The	   length	   of	   the	   barcode	   differs	   substantially	   between	   different	   experiments	  and	  depends	  on	  the	  expected	  number	  of	  identical	  template	  molecules.	  Grün	  et	  al	  found	  that	  using	  a	  molecular	  barcode	  as	  small	  as	  4	  nt	  reduced	  technical	  noise	  in	  single-­‐cell	   RNA	   sequencing	   for	   almost	   all	   genes	   with	   about	   50%	   on	   average,	  compared	  to	  not	  using	  the	  barcode	  (69).	  	  	  There	  are	  a	  number	  of	  pitfalls	  using	  molecular	  barcodes.	  First,	  errors	  in	  the	  UMI	  can	   easily	   cause	   an	   artificially	   high	   estimation	   of	   number	   of	   molecules.	   The	  longer	   the	   UMI	   and	   the	   more	   rounds	   of	   amplification	   used	   the	   higher	   the	  probability	   of	   UMI	   artefacts.	   Three	   approaches	   have	   been	   taken	   to	   solve	   this	  problem.	  UMI	  molecules	  with	  single	  or	  few	  reads	  can	  be	  removed.	  Amplification	  errors	  are	  clonal	  but	  most	  of	  them	  arise	  in	  the	  late	  rounds	  of	  amplification	  and	  are	  usually	  not	  represented	  by	  more	  than	  one	  or	  a	  couple	  of	  sequencing	  reads,	  although	  this	  depends	  of	  the	  sequencing	  depth.	  In	  comparison	  sequencing	  errors	  are	  random	  and	  are	  therefore	  often	  only	  represented	  by	  on	  one	  read.	  Both	  can	  therefore	   often	   be	   removed	   by	   filtering	   away	   UMI’s	   with	   low	   read	   count.	  Another,	   and	   complementary,	   approach	   is	   to	   collapse	   UMIs	   with	   a	   Hamming	  distance	   of	   1	   or	   2	   depending	   on	   the	   length	   of	   the	   UMI.	   A	   prerequisite	   of	   this	  approach	  is	  that	  there	  are	  enough	  random	  barcodes	  in	  relation	  to	  the	  number	  of	  template	  molecules	   so	   that	   it	   is	   very	   unlikely	   that	   two	   UMIs	   have	   a	   Hamming	  distance	  of	  2	  or	  less.	  The	  third	  approach	  is	  to	  use	  UMI	  with	  a	  defined	  barcode	  set	  with	  a	  known	  Hamming	  distance.	  This	   is	   feasible	   for	  paired	  end	  sequencing	  as	  shown	  by	  Shiroguchi	  et	  al.	  	  	  The	  second	  pitfall	  has	  to	  do	  with	  collision	  events.	  It	  is	  important	  that	  the	  number	  of	   barcodes	   is	   in	   large	   excess	   of	   the	   number	   of	   identical	   template	   molecules.	  Generally,	   it	   is	   good	   if	   the	   number	   of	   template	   molecules	   are	   fewer	   than	   the	  square	   root	   of	   the	   number	   of	   barcodes	   (40).	   Even	   with	   fewer	   barcodes	   it	   is	  possible	   to	  make	  an	  estimation	  of	   the	  number	  of	   input	   templates	  based	  on	   the	  read	  distribution	  of	  those	  barcodes,	  and	  generally	  exact	  quantification	  becomes	  less	  crucial	  for	  abundant	  templates.	  	  	  The	  third	  pitfall	  has	  to	  do	  with	  redundant	  sequencing.	  UMIs	  should	  preferentially	  be	   sequenced	   to	   saturation	   for	   exact	   quantification	   and	   error	   correction.	   In	  practice	  this	  means	  that	  each	  molecule	  should	  be	  sequenced	  at	  least	  once	  to	  be	  sure	  that	  all	  molecules	  have	  been	  detected,	  and	  preferably	  more	  times	  to	  allow	  for	  error	  correction.	  This	  requirement	  reduces	  the	  yield	  of	  barcoding	  strategies	  compared	  with	  standard	  sequencing	  methods.	  	  	  It	   is	   also	   important	   to	  note	   that	   although	   standard	  UMI	  barcoding	  will	  make	   it	  possible	  to	  measure	  molecules	  in	  an	  absolute	  scale,	  there	  are	  often	  other	  biases	  in	   the	   library.	  E.g.	   in	   single-­‐cell	  RNA	  sequencing	  UMI	   label	   cDNA,	  which	  means	  that	   RNA	   templates	   not	   converted	   to	   cDNA	   will	   not	   be	   counted.	   Also	   low	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Table	  1.	  Properties	  of	  molecular	  barcoding	  strategies	  	  	  












Affected	  by	  PCR	  
errors	   Yes	   Few	   Few	   Very	  few	   No	   No	  
Affected	  by	  
sequencing	  
errors	   Yes	   No	   No	   No	   No	   Yes	  
Affected	  by	  DNA	  
damaged	  in	  one	  
strand	   Yes	   Yes	   Yes	   No	   Yes*	   Yes	  
Yield	   High	   Low	   Low	   Very	  Low	   High	   Very	  High	  
Input	  material	  
required	   Low	   Low	   Low	   Low	   High	   Medium	  
Accurate	  
quantification	   No	   Yes	   Yes	   Yes	   Yes	   Yes	  
Introduction	  of	  
uninformative	  
molecules	   Yes	   Yes	   Yes	   Yes	   No**	   No	  
Even	  
representation	  of	  
genomic	  regions	   No	   No	   No	   No	   Yes	   Yes	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3	   RESULTS	  	  
3.1	   PAPER	  I:	  COUNTING	  ABSOLUTE	  NUMBERS	  OF	  MOLECULES	  USING	  
UNIQUE	  MOLECULAR	  IDENTIFIERS	  	  Paper	   I	   introduces	   the	   concept	   of	   Unique	   Molecular	   Identifiers	   (UMI)	   in	   RNA	  sequencing	   and	   in	   karyotyping	   of	   genomic	   DNA.	   The	   paper	   suggests	   two	  different	   methods	   of	   making	   molecules	   unique	   before	   amplification,	   by	   either	  	  degenerate	   barcoding	   or	   random	   fragmentation	   and	   dilution	   so	   each	  molecule	  receives	  a	  unique	  starting	  position	  in	  the	  genome	  with	  a	  high	  probability.	  	  	  Paper	   I	   showed	   that	  using	  UMI	   in	  RNA	  sequencing	  substantially	   reduces	  noise.	  There	  was	  a	  marked	  improvement	  in	  correlation	  between	  genes	  sequenced	  after	  15	  cycles	  of	  amplification	  compared	  to	  25	  cycles	  of	  amplification	  when	  counting	  molecules	   instead	   of	   reads.	   This	   indicated	   that	   the	   additional	   10	   cycles	   of	  amplification	   didn’t	   skew	   the	   representation	   of	   molecules,	   however	   the	  difference	   in	   copy	   number	   of	   molecules	   changed	   and	   created	   noise	   when	  counting	  reads.	  	  Counting	  molecules	   instead	   of	   reads	   also	   showed	   a	   drastic	   reduction	   of	   noise	  when	  used	  in	  non-­‐invasive	  prenatal	  testing	  (NIPT)	  of	  fetal	  karyotype,	  measured	  as	   coefficient	   of	   variation	   (CV,	   standard	   deviation	   /	   mean)	   between	   genomic	  regions.	   It	   was	   also	   shown	   that	   increased	   sequencing	   depth	   could	   not	   reduce	  noise	  when	  counting	  reads.	  	  	  
3.2	   PAPER	  II:	  AMPLIFICATION-­‐FREE	  SEQUENCING	  OF	  CELL-­‐FREE	  DNA	  FOR	  
NON-­‐INVASIVE	  PRENATAL	  TESTING	  OF	  FETAL	  CHROMOSOMAL	  
ABERRATIONS	  	  Reduction	  of	  noise	  in	  sequencing	  data	  is	  of	  particular	  importance	  in	  the	  clinical	  setting	  where	   low	   accuracy	   can	   lead	   to	   an	   erroneous	   decision	   by	   a	   physician,	  which	  in	  turn	  can	  have	  fundamental	  consequences	  for	  the	  patient.	  	  When	  cells	  die	  their	  DNA	  is	  fragmented	  and	  enters	  the	  blood	  stream.	  It	  has	  been	  known	  for	  a	  long	  time	  that	  this	  so	  called	  cell-­‐free	  DNA	  (cfDNA)	  exists,	  and	  it	  has	  been	   tested	   for	  monitoring	   cancer	   progression.	   In	   1997	   Dennis	   Lo	   discovered	  that	  cfDNA	  from	  the	  foetus	  can	  be	  found	  in	  the	  maternal	  blood	  stream	  (70).	  This	  discovery	   led	   to	   some	   immediate	   clinical	   applications	   like	   tests	   for	   sex	   and	  Rhesus	  factor.	  With	  the	  advent	  of	  NGS,	  fetal	  cfDNA	  was	  also	  used	  for	  NIPT	  of	  fetal	  karyotype	   (71).	   This	   is	   complicated	   by	   the	   fact	   that	   fetal	   cfDNA	   is	  mixed	   in	   a	  much	   larger	   pool	   of	   maternal	   cfDNA.	   The	   accuracy	   of	   NIPT	   methods	   were	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dependent	  of	  the	  chromosome	  examined	  and	  most	  methods	  performed	  worse	  on	  chromosomes	  with	  aberrant	  GC	  content.	  	  	  It	  was	  hypothesized	  that	  molecular	  barcoding	  would	   increase	  accuracy	  of	  NIPT	  leading	   to	   more	   correct	   clinical	   decisions.	   However	   clinical	   reality	   has	   many	  parameters	  to	  take	  into	  account	  and	  it	  was	  soon	  discovered	  that	  the	  low	  yield	  of	  the	   UMI	   method	   would	   make	   it	   too	   costly	   to	   implement.	   Therefore	   an	  amplification-­‐free	   library	  preparation	  protocol	  was	  developed	   that	   successfully	  produced	   libraries	   from	   the	   small	   amount	   of	   cfDNA	   extractable	   from	   plasma	  samples.	  If	  amplification	  is	  removed	  from	  the	  library	  preparation	  a	  large	  part	  of	  the	   bias	   associated	   with	   it	   is	   removed.	   An	   added	   benefit	   of	   amplification-­‐free	  protocols	  is	  that	  each	  read	  is	  informative,	  that	  is	  no	  non-­‐informative	  copies	  of	  a	  molecules	  are	  sequenced,	  which	  in	  turn	  allows	  for	  fewer	  reads	  to	  be	  sequenced.	  	  	  Paper	  II	  showed	  that	  the	  amplification-­‐free	  library	  preparation	  method	  could	  be	  used	  to	  correctly	   identify	   the	  karyotype	  of	  27	   foetuses,	  of	  which	  15	  had	  one	  or	  more	   aberrant	   karyotypes,	   using	   cfDNA	   from	  maternal	   plasma.	   It	   also	   showed	  that	   both	   the	   amplification-­‐free	   library	   preparation	   and	   the	   UMI	   method	  substantially	  lowered	  bias	  in	  karyotyping	  when	  a	  single	  sample	  was	  mapped	  to	  the	  genome.	  However	  when	  a	  sample	  was	  normalized	  to	  a	  control	  there	  was	  no	  clear	   benefit	   neither	   for	   the	   amplification-­‐free	   nor	   the	   UMI	   method.	   This	  phenomenon	  is	  likely	  due	  to	  that	  the	  bias	  introduced	  by	  PCR	  is	  highly	  conserved	  between	   samples,	   and	  when	   a	   sample	   produced	  with	   a	   standard	   amplification	  protocol	   is	   compared	   with	   another	   sample	   the	   bias	   can	   be	   identified	   and	  accounted	  for.	  	  
3.3	  	   PAPER	  III:	  ALTERNATIVE	  PROMOTERS	  ARE	  CO-­‐REGULATED	  IN	  SINGLE	  
CELLS	  IN	  THE	  MOUSE	  BRAIN	  
	  An	  organ	  consists	  of	  a	  multitude	  of	  single	  cells	  that	  interact	  in	  complex	  ways.	  A	  reductionist	   view	   of	   studying	   organ	   function	  would	   be	   to	   study	   the	   individual	  parts	  of	  the	  organ,	  i.e.	  the	  single	  cells	  making	  up	  the	  organ.	  Until	  recently	  this	  has	  been	   very	   difficult	   to	   do,	   apart	   from	   studying	   the	   morphology	   or	   individual	  mRNA	   transcripts	   or	   proteins,	   and	   describing	   a	   cell	   solely	   on	   morphology	   is	  clearly	   inadequate.	   Recent	   advances	   in	   single-­‐cell	   RNA-­‐sequencing	   is	   about	   to	  change	  this,	  and	  there	  is	  an	  on-­‐going	  debate	  in	  the	  field	  on	  how	  to	  define	  a	  cell	  type.	   Studying	   biology	   at	   the	   single-­‐cell	   level	   increases	   the	   resolution	   of	   the	  process	  studied,	  compared	  to	  studying	  a	  mixture	  of	  cells	  at	  the	  same	  time.	  E.g.	  a	  gene	   moderately	   expressed	   at	   the	   bulk	   level	   could	   either	   be	   moderately	  expressed	  in	  all	  cells	  or	  be	  highly	  expressed	  in	  some	  cells	  and	  not	  expressed	  in	  others.	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The	   definition	   of	   a	   promoter	   is	   a	   “DNA	   sequence(s)	   that	   define	   where	  transcription	  of	  a	  gene	  by	  RNA	  polymerase	  begins”	  (72).	  Promoters	  are	  typically	  located	  directly	  upstream	  of	  the	  TSS,	  and	  are	  bound	  by	  the	  RNA	  polymerase	  and	  with	  it	  associated	  factors	  to	  initiate	  transcription.	  Initially	   it	  was	  thought	  that	  a	  gene	  has	   only	   one	  promoter,	   but	   it	   has	  now	  been	   shown	   that	   a	   gene	   can	  have	  several	   promoters	   (73).	   Since	   the	   advent	   of	   NGS	   promoter	   usage	   has	   been	  studied	  in	  detail,	  however	  it	  has	  not	  been	  done	  in	  single	  cells.	  	  Using	  STRT	  in	  combination	  with	  UMIs,	  Paper	  III	  showed	  that	  if	  a	  gene	  expresses	  transcripts	   from	   two	   promoters	   in	   the	   bulk	   population	   it	   usually	   expresses	  transcripts	   from	   both	   promoters	   also	   in	   single	   cells.	   Interestingly	   these	   two	  promoters	  are	  generally	  expressed	  in	  a	  conserved	  ratio	  across	  cells	  of	  a	  specific	  cell	  type,	  in	  contrast	  with	  gene	  expression	  level	  that	  varies	  considerably	  between	  cells.	  Typically	   the	   ratio	  between	   the	  major	  promoter	   and	   the	  minor	  promoter	  are	  also	  conserved	  across	  cell	  types,	  but	  here	  specific	  genes	  can	  change	  the	  ratio	  of	   expression,	   and	   in	   some	   cases	   the	  minor	   promoter	   is	   also	   higher	   expressed	  than	   the	   major.	   When	   comparing	   two	   different	   neuronal	   cell	   types	   few	   genes	  significantly	  change	  the	  ratio	  of	  promoter	  expression,	  however	  when	  comparing	  a	   neuronal	   and	   a	   non-­‐neuronal	   cell	   type	   in	   the	   mouse	   brain,	   the	   change	   of	  expression	   is	   more	   common,	   indicating	   that	   genes	   governing	   the	   neuronal	  phenotype	   also	   influence	   promoter	   preference.	   A	   major	   conclusion	   from	   this	  paper	   is	   that	   promoter	   expression	   in	   a	   cell	   type	   is	   generally	   governed	   by	   a	  common	   factor	   that	   influences	   both	   the	   major	   and	   minor	   promoter,	   although	  with	  different	  affinity.	  This	  conclusion	  is	  somewhat	  supported	  by	  the	  discovery	  that	  neighbouring	  promoters	  often	  interact	  with	  each	  other	  (74)	  and	  that	  active	  promoters	  tend	  to	  influence	  the	  expression	  of	  neighbouring	  genes	  (75).	  	  	  
3.4	   PAPER	  IV:	  SINGLE-­‐CELL	  mRNA	  ISOFORM	  DIVERSITY	  IN	  THE	  MOUSE	  
BRAIN	  
	  Alternative	   isoform	  usage	   is	   known	   to	   be	   an	   important	   feature	   of	   our	   genome	  and	   allows	   it	   to	   create	   a	   highly	   diverse	   set	   of	   proteins	   from	   a	   relatively	   small	  number	  of	  genes.	  Two	  transcripts	  from	  the	  same	  gene	  can	  differ	  from	  each	  other	  in	   many	   ways.	   Their	   start	   or	   end	   position	   could	   differ,	   potentially	   leading	   to	  different	  degradation	  kinetics.	  Their	  exon	  composition	  could	  vary,	  or	  transcripts	  could	  retain	  introns	  during	  splicing,	  leading	  to	  severely	  altered	  proteins.	  Finally	  they	  could	  vary	  in	  exon	  end	  or	  start	  positions.	  	  	  In	  theory	  each	  gene	  could	  be	  represented	  by	  many	  different	  isoforms,	  and	  there	  are	   certain	   indications	   that	   they	   indeed	   are.	   A	   recent	   study	   by	   the	   Encode	  consortium	  found	  that	  the	  number	  of	  expressed	  isoforms	  in	  a	  cell	  line	  tended	  to	  follow	   the	   number	   of	   annotated	   isoforms	   up	   to	   10-­‐12	   isoforms	   expressed	   per	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gene	   (76).	   Another	   study	   by	   the	   FANTOM	   consortium	   found	   that	   on	   average	  human	  genes	  have	  four	  robust	  CAGE	  peaks	  within	  500	  bp	  from	  the	  annotated	  5’	  end	  of	  the	  gene	  (73).	  Both	  these	  studies	  have	  been	  done	  on	  bulk	  material	  and	  the	  amount	  of	  isoform	  diversity	  at	  the	  single	  cell	  level	  is	  unknown.	  	  	  Paper	   IV	   takes	  advantage	  of	   the	  PacBio	   long	  read	  sequencing	  platform	  and	   the	  increased	  accuracy	  achieved	  with	  UMI	  molecule	  counting	  to	  examine	  full	  length	  mRNA	  for	  the	  whole	  transcriptome	  at	  the	  single	  cell	   level.	  The	  major	  finding	  in	  paper	   IV	   is	   that	   a	   large	   part	   of	   all	   mRNA	  molecules	   in	   a	   single	   cell	   constitute	  separate	   isoforms,	   even	   after	   applying	   a	   conservative	   definition	   of	   what	  constitutes	  an	   isoform.	  Also	  relatively	   few	  isoforms	  are	  common	  between	  cells.	  Another	   finding	   was	   that	   exon	   junctions	   in	   coding	   regions	   show	   less	   isoform	  diversity	  than	  exon	  junction	  in	  non-­‐coding	  regions.	  In	  conclusion	  genes	  express	  a	  surprisingly	  high	  number	  of	  isoforms	  also	  in	  single	  cells,	  which	  indicates	  that	  the	  transcriptional	  machinery	  can	  afford	  to	  be	  a	  bit	  inaccurate,	  especially	  outside	  of	  the	  coding	  region.	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4	   PERSPECTIVES	  	  	  Molecular	   biology	   is	   in	   an	   intensive	   phase	   of	   making	   new	   discoveries.	   Two	  events	  stand	  out	  as	  being	  especially	  important	  in	  providing	  a	  framework	  for	  new	  innovations:	   The	   sequencing	   of	   the	   human	   genome	   and	   the	   advent	   of	   next	  generation	  sequencing.	  The	  development	  of	  methods	   to	  get	   information	  on	   the	  genome,	  transcriptome	  and	  even	  proteome	  at	  the	  single	  cell	  level	  has	  shown	  that	  single	  cells	  are	  more	  heterogeneous	  than	  previously	  thought,	  which	  will	  have	  an	  impact	  both	  on	  basic	  research	  and	  medicine.	  	  	  The	  early	  days	  of	  molecular	  biology	  were	  preoccupied	  with	  figuring	  out	  how	  the	  flow	  of	   information	  went	   from	  DNA	   to	  RNA	   to	   protein.	   Today	   a	   lot	   of	   effort	   is	  spent	  on	  understanding	  the	  regulation	  of	  those	  steps,	  how	  transcription	  factors	  and	  other	  epigenetic	  elements	  combine	  to	  turn	  on	  and	  off	  genes.	  	  	  Although	   it	   is	   always	   risky	   to	   predict	   the	   future	   some	   general	   trends	   can	   be	  discerned	  that	  will	  likely	  influence	  molecular	  biology	  in	  the	  coming	  years.	  Many	  efforts	  are	  ongoing	  to	  make	  sequencing	  cheaper,	  easier,	  quicker	  and	  with	  longer	  reads.	   Today	   Illumina’s	   short	   read	   technology	   is	   dominating	   the	   sequencing	  market,	   and	   it	   is	   used	   in	   a	  number	  of	   applications	   from	   targeted	   resequencing	  and	   diagnostics,	   to	   de	   novo	   genome	   assembly.	   Other	   technologies	   are	   now	  maturing	   and	   it	   seems	   likely	   that	   some	   of	   these	   technologies	   will	   take	   over	  certain	  sectors	  of	  the	  market,	  like	  de	  novo	  genome	  sequencing	  and	  in	  diagnostic	  applications	  where	  time	  or	  convenience	  is	  a	  limiting	  factor.	  	  	  Another	  trend	  is	  that	  single	  cell	  sequencing	  technologies	  will	  grow	  in	  popularity.	  During	  the	  last	  five	  years	  single-­‐cell	  RNA	  sequencing	  has	  transformed	  from	  being	  performed	   by	   a	   few	   laboratories,	   and	   limited	   to	   sequencing	   a	   few	   cells,	   to	  becoming	  a	  routine	  procedure	  offered	  by	  core	  facilities.	  A	  number	  of	  commercial	  alternatives	  now	  exist	  that	  can	  prepare	  single-­‐RNA	  sequencing	  libraries	  of	  up	  to	  48,000	  cells	  at	  a	   time	  (77).	  Single-­‐cell	  experiments	  are	  also	   likely	   to	  measure	  a	  growing	  number	  of	  parameters	  per	  cell,	  such	  as	  combining	  transcriptomics	  and	  proteomics,	   or	   transcriptomics	   and	  DNA	   sequencing	   (78,	   79).	  Another	   trend	   is	  that	  single	  cell	  sequencing	  is	  done	  in	  situ,	  which	  has	  already	  been	  demonstrated	  by	  several	  groups	  (80,	  81).	  So	  far	  most	  single-­‐cell	  RNA-­‐sequencing	  experiments	  have	  been	  concerned	  with	  characterizing	  the	  normal	  state	  of	  cells,	  but	  more	  and	  more	  studies	  are	  done	  on	  perturbed	  states,	  like	  in	  disease	  or	  after	  exposure	  to	  a	  drug.	   I	   believe	   the	   frontier	   of	   single	   cell	   experiments	   will	   soon	   move	   on	   to	  examination	   of	   single	   cells	   in	   their	   natural	   environment,	   and	   cell-­‐cell	  interactions,	  since	  expression	  has	  been	  shown	  to	  be	  strongly	  influenced	  by	  other	  cells	  and	  the	  local	  niche.	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Molecular	   barcodes	   are	   already	   commonly	   used	   in	   single-­‐cell	   RNA	   sequencing	  experiments.	   They	   have	   been	   successfully	   used	   in	   targeted	   resequencing	   and	  other	   fields	   of	   molecular	   biology	   to	   increase	   accuracy	   of	   sequencing,	   and	   will	  surely	  get	  more	  generally	  accepted	  by	  the	  sequencing	  community.	  	  	  Finally,	   I	  believe	   the	  coming	  years	  will	   see	  many	  more	  examples	  of	  sequencing	  being	   used	   in	   the	   clinic.	   Currently	  monogenic	   diseases	   are	   being	   screened	   and	  chromosomal	   aberrations	   are	   investigated	   in	   cancer	   and	   prenatal	   diagnostics.	  Coming	   genetic	   tests	   may	   include	   testing	   total	   viral	   load	   in	   blood	   and	   gut	  bacteria	  composition.	  Liquid	  biopsies	  of	   the	  blood	   is	  also	  coming	  of	  age,	  where	  circulating	   tumour	   cells,	   tumour-­‐related	   cell-­‐free	   DNA,	   or	   exosomes	   can	   be	  studied,	   allowing	   the	   doctor	   to	   on	   a	   daily	   basis	   see	   the	   genetic	   part	   of	   disease	  progression.	   With	   refined	   diagnostic	   tools	   personalized	   medicine	   will	   be	  transformed	  from	  anecdotal	  to	  standard	  medical	  practice.	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